+

US20060020330A1 - Method of fabricating an implantable medical device with biaxially oriented polymers - Google Patents

Method of fabricating an implantable medical device with biaxially oriented polymers Download PDF

Info

Publication number
US20060020330A1
US20060020330A1 US10/899,948 US89994804A US2006020330A1 US 20060020330 A1 US20060020330 A1 US 20060020330A1 US 89994804 A US89994804 A US 89994804A US 2006020330 A1 US2006020330 A1 US 2006020330A1
Authority
US
United States
Prior art keywords
tube
film
polymer
annular
implantable medical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US10/899,948
Other languages
English (en)
Inventor
Bin Huang
Stephen Schaible
Richard Kaufman
Jim Kennedy
David Gale
Suresh Amin
John Guardiano
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott Cardiovascular Systems Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US10/899,948 priority Critical patent/US20060020330A1/en
Application filed by Individual filed Critical Individual
Assigned to ADVANCED CARDIOVASCULAR SYSTEMS, INC. reassignment ADVANCED CARDIOVASCULAR SYSTEMS, INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: GUARDIANO, JOHN, AMIN, SURESH, KENNEDY, JIM, SCHAIBLE, STEPHEN, GALE, DAVID C., HUANG, BIN, KAUFMAN, RICHARD
Priority to JP2007523649A priority patent/JP4782121B2/ja
Priority to EP05773427.9A priority patent/EP1773566B1/fr
Priority to PCT/US2005/025759 priority patent/WO2006014747A1/fr
Publication of US20060020330A1 publication Critical patent/US20060020330A1/en
Priority to US12/806,785 priority patent/US8192678B2/en
Priority to US13/463,562 priority patent/US8715564B2/en
Priority to US13/998,199 priority patent/US9517149B2/en
Priority to US13/998,204 priority patent/US20140114394A1/en
Priority to US13/998,195 priority patent/US20140128959A1/en
Priority to US13/998,194 priority patent/US20140107761A1/en
Priority to US14/252,708 priority patent/US20140228929A1/en
Abandoned legal-status Critical Current

Links

Images

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
    • B29C48/00—Extrusion moulding, i.e. expressing the moulding material through a die or nozzle which imparts the desired form; Apparatus therefor
    • B29C48/25—Component parts, details or accessories; Auxiliary operations
    • B29C48/30—Extrusion nozzles or dies
    • B29C48/32—Extrusion nozzles or dies with annular openings, e.g. for forming tubular articles
    • B29C48/33—Extrusion nozzles or dies with annular openings, e.g. for forming tubular articles with parts rotatable relative to each other
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L31/148—Materials at least partially resorbable by the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A61F2/90—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
    • A61F2/91—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheets or tubes, e.g. perforated by laser cuts or etched holes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2002/825—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents having longitudinal struts
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B23—MACHINE TOOLS; METAL-WORKING NOT OTHERWISE PROVIDED FOR
    • B23K—SOLDERING OR UNSOLDERING; WELDING; CLADDING OR PLATING BY SOLDERING OR WELDING; CUTTING BY APPLYING HEAT LOCALLY, e.g. FLAME CUTTING; WORKING BY LASER BEAM
    • B23K2103/00—Materials to be soldered, welded or cut
    • B23K2103/30—Organic material
    • B23K2103/42—Plastics
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B23—MACHINE TOOLS; METAL-WORKING NOT OTHERWISE PROVIDED FOR
    • B23K—SOLDERING OR UNSOLDERING; WELDING; CLADDING OR PLATING BY SOLDERING OR WELDING; CUTTING BY APPLYING HEAT LOCALLY, e.g. FLAME CUTTING; WORKING BY LASER BEAM
    • B23K2103/00—Materials to be soldered, welded or cut
    • B23K2103/50—Inorganic material, e.g. metals, not provided for in B23K2103/02 – B23K2103/26
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
    • B29C48/00—Extrusion moulding, i.e. expressing the moulding material through a die or nozzle which imparts the desired form; Apparatus therefor
    • B29C48/001—Combinations of extrusion moulding with other shaping operations
    • B29C48/0018—Combinations of extrusion moulding with other shaping operations combined with shaping by orienting, stretching or shrinking, e.g. film blowing
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
    • B29C48/00—Extrusion moulding, i.e. expressing the moulding material through a die or nozzle which imparts the desired form; Apparatus therefor
    • B29C48/03—Extrusion moulding, i.e. expressing the moulding material through a die or nozzle which imparts the desired form; Apparatus therefor characterised by the shape of the extruded material at extrusion
    • B29C48/09—Articles with cross-sections having partially or fully enclosed cavities, e.g. pipes or channels
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
    • B29C49/00—Blow-moulding, i.e. blowing a preform or parison to a desired shape within a mould; Apparatus therefor
    • B29C49/42—Component parts, details or accessories; Auxiliary operations
    • B29C49/78—Measuring, controlling or regulating
    • B29C49/786—Temperature
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29L—INDEXING SCHEME ASSOCIATED WITH SUBCLASS B29C, RELATING TO PARTICULAR ARTICLES
    • B29L2031/00—Other particular articles
    • B29L2031/753—Medical equipment; Accessories therefor
    • B29L2031/7532—Artificial members, protheses
    • B29L2031/7534—Cardiovascular protheses

Definitions

  • This invention relates to methods of fabricating implantable medical devices such as stents.
  • This invention relates to radially expandable endoprostheses which are adapted to be implanted in a bodily lumen.
  • An “endoprosthesis” corresponds to an artificial implantable medical device that is placed inside the body.
  • a “lumen” refers to a cavity of a tubular organ such as a blood vessel.
  • a stent is an example of these endoprostheses.
  • Stents are generally cylindrically shaped devices which function to hold open and sometimes expand a segment of a blood vessel or other anatomical lumen such as urinary tracts and bile ducts. Stents are often used in the treatment of atherosclerotic stenosis in blood vessels.
  • Step refers to a narrowing or constriction of the diameter of a bodily passage or orifice.
  • stents reinforce body vessels and prevent restenosis following angioplasty in the vascular system.
  • Restenosis refers to the reoccurrence of stenosis in a blood vessel or heart valve after it has been treated (as by balloon angioplasty or valvuloplasty) with apparent success.
  • Stents have been made of many materials including metals and polymers.
  • Polymer materials include both nonbioerodable and bioerodable plastic materials.
  • the cylindrical structure of stents is typically composed of a scaffolding that includes a pattern or network of interconnecting structural elements or struts.
  • the scaffolding can be formed from wires, tubes, or planar films of material rolled into a cylindrical shape.
  • a medicated stent may be fabricated by coating the surface of either a metallic or polymeric scaffolding with a polymeric carrier.
  • the polymeric carrier can include an active agent or drug.
  • the pattern that makes up the stent allows the stent to be radially expandable and longitudinally flexible.
  • the pattern should be designed to maintain the longitudinal flexibility and rigidity required of the stent.
  • a stent should also have adequate strength in the circumferential direction.
  • a number of techniques have been suggested for the fabrication of stents from tubes and planar films or sheets.
  • One such technique involves laser cutting or etching a pattern onto a material. Laser cutting may be performed on a planar film of a material which is then rolled into a tube. Alternatively, a desired pattern may be etched directly onto a tube. Other techniques involve cutting a desired pattern into a sheet or a tube via chemical etching or electrical discharge machining. Laser cutting of stents has been described in a number of publications including U.S. Pat. No. 5,780,807 to Saunders, U.S. Pat. No. 5,922,005 to Richter and U.S. Pat. No. 5,906,759 to Richter.
  • a treatment involving a stent involves both delivery and deployment of the stent.
  • Delivery refers to introducing and transporting the stent through a bodily lumen to a region requiring treatment.
  • Delivery and deployment of a stent corresponds to the expanding of the stent within the lumen at the treatment region. Delivery and deployment of a stent are accomplished by positioning the stent about one end of a catheter, inserting the end of the catheter through the skin into a bodily lumen, advancing the catheter in the bodily lumen to a desired treatment location, expanding the stent at the treatment location, and removing the catheter from the lumen.
  • the stent is mounted about a balloon disposed on the catheter.
  • Mounting the stent typically involves compressing or crimping the stent onto the balloon.
  • the stent is then expanded by inflating the balloon.
  • the balloon may then be deflated and the catheter withdrawn.
  • the stent may be secured to the catheter via a retractable sheath or a sock. When the stent is in a desired bodily location, the sheath may be withdrawn allowing the stent to self-expand.
  • a stent it is desirable for a stent to have certain mechanical properties to facilitate delivery and deployment of a stent. For example, longitudinal flexibility is important for successful delivery of the stent. In addition, circumferential strength and rigidity and are vital characteristics in deployment and for holding open a body lumen. As indicated above, the pattern of the stent may be designed to provide longitudinal flexibility and rigidity.
  • stents fabricated from polymers are that they tend to possess greater flexibility than metal stents.
  • Other potential shortcomings of metal stents include adverse reactions from the body, nonbioerodability, and non-optimal drug-delivery.
  • polymer stents compared to metal stents is that polymer stents typically have less circumferential strength and rigidity. Inadequete circumferential strength potentially contributes to relatively high recoil of polymer stents after implantation into vessels.
  • polymer stents can crack during crimping, especially for brittle polymers. Therefore, methods of manufacturing polymer stents that improve circumferential strength and rigidity are desirable.
  • the embodiments of the present invention address the issue of improving circumferential strength and rigidity in polymer stents.
  • the present invention is directed to methods for fabricating an implantable medical device, such as a stent, from a tube, with desirable mechanical properties, such as improved circumferential strength and rigidity. Improved circumferential strength and rigidity may be obtained by inducing circumferential molecular orientation in materials for use in manufacturing an implantable medical device.
  • Various embodiments of the present invention include methods for inducing circumferential molecular orientation in a material.
  • Certain embodiments of methods of manufacturing an implantable medical device include introducing a polymer into a forming apparatus.
  • the forming apparatus may include a first annular member disposed within a second annular member.
  • the polymer may be conveyed through an annular chamber as an annular film between the annular members.
  • Some embodiments may include radially expanding the annular film. Expansion may be performed after the annular film exits the apparatus.
  • the method may further include forming a tube from the expanded annular film.
  • the method may also include fabricating an implantable medical device from the tube.
  • inventions may include a method including introducing a polymer into a forming apparatus.
  • the forming apparatus may include a first annular member disposed within a second annular member.
  • the polymer may be conveyed through an annular chamber as an annular film between the annular members.
  • the method may further include inducing circumferential flow in the annular film.
  • the method may also include forming a tube from the annular film.
  • Some embodiments may include fabricating an implantable medical device from the tube.
  • Some embodiments of the present invention may include a method of fabricating an implantable medical device that includes radially expanding a tube about a cylindrical axis of the tube from a first diameter to a second diameter. The method may further include fabricating an implantable medical device from the expanded tube that has a second diameter greater than the first diameter.
  • Certain embodiments of the present invention may include a method of manufacturing an implantable medical device that includes stretching a film along a first axis of stretching and stretching a film along a second axis of stretching. The method may further include fabricating an implantable medical device from the stretched film.
  • the present invention may further include an apparatus for manufacturing an implantable medical device that includes a first zone and a second zone.
  • the first zone may include a first annular member and a second annular member.
  • the first annular member may be disposed within the second annular member so as to provide for an annular chamber between the first and second annular members.
  • the annular chamber may be configured to receive a material and dispense the material as an annular film to a second zone.
  • the second zone may include a space for allowing radial pressure to be applied to the annular film to expand the material from a first film diameter to a second, larger film diameter.
  • FIG. 1 depicts a tube.
  • FIG. 2 depicts a three-dimensional rendering of an implantable medical device with a pattern.
  • FIG. 3 depicts a system and method of manufacturing an implantable medical device.
  • FIG. 4A depicts a radial cross-section of a forming apparatus.
  • FIGS. 4B-7 depict an axial cross-section of a forming apparatus.
  • FIGS. 8A and 8B depict a method of expanding a tube.
  • FIG. 9 depicts an x-y coordinate plane.
  • FIG. 10A depicts a film.
  • FIG. 10B depicts a tube.
  • Stress refers to force per unit area, as in the force acting through a small area within a plane. Stress can be divided into components, normal and parallel to the plane, called normal stress and shear stress, respectively. True stress denotes the stress where force and area are measured at the same time. Conventional stress, as applied to tension and compression tests, is force divided by the original gauge length.
  • elastic deformation refers to deformation of an object in which the applied stress is small enough so that the object retains its original dimensions or essentially its original dimensions once the stress is released.
  • Elastic limit refers to the maximum stress that a material will withstand without permanent deformation.
  • plastic deformation refers to permanent deformation that occurs in a material under stress after elastic limits have been exceeded.
  • “Strength” refers to the maximum stress along an axis in testing which a material will withstand prior to fracture. The ultimate strength is calculated from the maximum load applied during the test divided by the original cross-sectional area.
  • Modulus may be defined as the ratio of the stress or force per unit area applied to a material divided by the amount of strain resulting form the applied force.
  • Stress refers to the amount of elongation or compression that occurs in a material at a given stress or load.
  • Elongation may be defined as the increase in length which occurs when subjected to stress. It is typically expressed as a percentage of the original length.
  • solvent is defined as a substance capable of dissolving or dispersing one or more other substances or capable of at least partially dissolving or dispersing the substance(s) to form a uniformly dispersed mixture at the molecular- or ionic-size level.
  • the solvent should be capable of dissolving at least 0.1 mg of the polymer in 1 ml of the solvent, and more narrowly 0.5 mg in 1 ml at ambient temperature and ambient pressure.
  • a second fluid can act as a non-solvent for the impurity.
  • Non-solvent is defined as a substance incapable of dissolving the other substance. The non-solvent should be capable of dissolving only less than 0.1 mg of the polymer in 1 ml of the non-solvent at ambient temperature and ambient pressure, and more narrowly only less than 0.05 mg in 1 ml at ambient temperature and ambient pressure.
  • Implantable medical device is intended to include self-expandable stents, balloon-expandable stents, stent-grafts, and grafts.
  • the structural pattern of the device can be of virtually any design.
  • the device can also be made partially or completely from a biodegradable, bioabsorbable, or biostable polymer. The polymer may be purified to remove undesirable materials.
  • Polymers can be biostable, bioabsorbable, biodegradable or bioerodable.
  • Biostable refers to polymers that are not biodegradable.
  • biodegradable, bioabsorbable, and bioerodable are used interchangeably and refer to polymers that are capable of being completely degraded and/or eroded when exposed to bodily fluids such as blood and can be gradually resorbed, absorbed and/or eliminated by the body.
  • the processes of breaking down and eventual absorption and elimination of the polymer can be caused by, for example, hydrolysis, metabolic processes, bulk or surface erosion, and the like.
  • the material is used in coating applications, it is understood that after the process of degradation, erosion, absorption, and/or resorption has been completed, no polymer will remain on the device. In some embodiments, very negligible traces or residue may be left behind.
  • the stent is intended to remain in the body for a duration of time until its intended function of, for example, maintaining vascular patency and/or drug delivery is accomplished.
  • polymers that may be used to fabricate an implantable medical device using the methods disclosed herein include poly(N-acetylglucosamine) (Chitin), Chitoson, poly(hydroxyvalerate), poly(lactide-co-glycolide), poly(hydroxybutyrate), poly(hydroxybutyrate-co-valerate), polyorthoester, polyanhydride, poly(glycolic acid), poly(glycolide), poly(L-lactic acid), poly(L-lactide), poly(D,L-lactic acid), poly(D,L-lactide), poly(caprolactone), poly(trimethylene carbonate), polyethylene amide, polyethylene acrylate, poly(glycolic acid-co-trimethylene carbonate), co-poly(ether-esters) (e.g.
  • PEO/PLA polyphosphazenes
  • biomolecules such as fibrin, fibrinogen, cellulose, starch, collagen and hyaluronic acid
  • polyurethanes silicones
  • polyesters polyolefins, polyisobutylene and ethylene-alphaolefin copolymers
  • acrylic polymers and copolymers other than polyacrylates vinyl halide polymers and copolymers (such as polyvinyl chloride), polyvinyl ethers (such as polyvinyl methyl ether), polyvinylidene halides (such as polyvinylidene chloride), polyacrylonitrile, polyvinyl ketones, polyvinyl aromatics (such as polystyrene), polyvinyl esters (such as polyvinyl acetate), acrylonitrile-styrene copolymers, ABS resins, polyamides (such as Nylon 66 and polycaprolactam), polycarbonates, polyoxymethylenes, polyimides,
  • polymers that may be especially well suited for use in fabricating an implantable medical device according to the methods disclosed herein include ethylene vinyl alcohol copolymer (commonly known by the generic name EVOH or by the trade name EVAL), poly(butyl methacrylate), poly(vinylidene fluoride-co-hexafluororpropene) (e.g., SOLEF 21508 , available from Solvay Solexis PVDF, Thorofare, N.J.), polyvinylidene fluoride (otherwise known as KYNAR, available from ATOFINA Chemicals, Philadelphia, Pa.), ethylene-vinyl acetate copolymers, and polyethylene glycol.
  • EVAL ethylene vinyl alcohol copolymer
  • poly(butyl methacrylate) poly(vinylidene fluoride-co-hexafluororpropene)
  • SOLEF 21508 available from Solvay Solexis PVDF, Thorofare, N.J.
  • a region of a polymeric material with a high degree of oriented crystalline structure tends to have high strength and rigidity along an axis of polymer chain alignment. Therefore, it may be desirable to incorporate processes that induce molecular orientation of polymer chains along a preferred axis or direction into manufacturing methods of implantable medical devices.
  • molecular orientation in a polymer may be induced, and hence mechanical properties modified, by applying stress to the polymer.
  • the degree of molecular orientation induced with applied stress may depend upon the temperature of the polymer. For example, below the glass transition temperature, T g , of a polymer, polymer segments may not have sufficient energy to move past one another. In general, molecular orientation may not be induced without sufficient segmental mobility.
  • the “glass transition temperature,” T g is the temperature at which the amorphous domains of a polymer change from a brittle vitreous state to a solid deformable state at atmospheric pressure.
  • the T g corresponds to the temperature where the onset of segmental motion in the chains of the polymer occurs.
  • T g of a given polymer can be dependent on the heating rate and can be influenced by the thermal history of the polymer. Furthermore, the chemical structure of the polymer heavily influences the glass transition by affecting mobility. Generally, flexible main-chain components lower the T g ; bulky side-groups raise the T g ; increasing the length of flexible side-groups lowers the T g ; and increasing main-chain polarity increases the T g . Additionally, the presence of crosslinking polymeric components can increase the observed T g for a given polymer.
  • T g molecular orientation may be readily induced with applied stress since rotation of polymer chains, and hence segmental mobility, is possible.
  • T m melting temperature of the polymer
  • the barriers are not great enough to substantially prevent segmental mobility.
  • the temperature of a polymer is increase above T g , the energy barriers to rotation decrease and segmental mobility of polymer chains tend to increase.
  • molecular orientation is more easily induced with applied stress.
  • T g and T m may induce molecular orientation of the polymer, and hence, modify its mechanical properties.
  • rearrangement of polymer chains may take place when a polymer is stressed in an elastic region and in a plastic region of the polymer material.
  • a polymer stressed beyond its elastic limit to a plastic region generally retains its stressed configuration and corresponding induced molecular orientation when stress is removed.
  • the polymer chains may become oriented in the direction of the applied stress which results in an oriented crystalline structure.
  • the stressed polymer material may have a higher tensile strength in the direction of the applied stress.
  • a plastically deformed material tends to retain its deformed configuration once the deforming stress is removed. Stress applied to the material subsequent to the initial deforming stress tends not to cause further deformation of the material unless the applied stress is greater than the initial stress level that caused the deformation. Therefore, the behavior of a plastically deformed material may be more predictable within a range of stress. The stress range may be less than the initial stress applied that caused the plastic deformation.
  • application of heat with stress may facilitate deformation of a polymer under stress, and hence, modification of the mechanical properties of the polymer.
  • a polymer deformed elastically with stress facilitated with applied heat may retain induced molecular orientation by cooling the polymer before relaxing to an unstrained state.
  • a polymer exists as a polymer melt or in a molten state.
  • a polymer melt there is a very small barrier to bond rotation, and hence, segmental mobility of polymer chains is very high.
  • the higher the temperature the greater the segmental mobility, or generally, the more intense the molecular motion. Therefore, applying stress to a polymer melt may also induce molecular orientation. Stress may be applied to a polymer melt in the form of a film as an isotropic stress or pressure which results in expansion of the film, as in a bubble. The expansion may result in circumferential molecular orientation in a direction of induced strain along the surface of the expanded film.
  • a shear stress may be applied which induces flow in the polymer melt.
  • the molecular orientation may tend to be in the direction or along an axis of applied shear stress or flow. However, due to intense molecular motion, the induced molecular orientation is not stable. Once the shear stress is removed or the flow slows or stops, molecular motion may tend to dissipate the molecular orientation.
  • the highest temperature at which molecular orientation is stable is less than or equal to the T m of the polymer. Therefore, it may be necessary to reduce the temperature of a polymer melt below T m to inhibit or prevent dissipation of molecular orientation.
  • FIG. 1 depicts a tube 100 .
  • Tube 100 is a cylinder with an outside diameter 110 and an inside diameter 120 .
  • FIG. 1 also depicts a surface 130 and a cylindrical axis 140 of tube 100 .
  • the “diameter” of the tube refers to the outside diameter of tube.
  • the diameter of the tube prior to fabrication of the implantable medical device may be between about 0.5 mm and about 3.0 mm. In other embodiments, the diameter of the tube prior to fabrication may be between about 1 mm and 2 mm.
  • An example of a tube prior to fabrication may include one with a diameter of 2.13 mm (0.084 in).
  • An implantable medical device may be fabricated from a polymer tube. Fabrication may include forming a pattern that includes at least one interconnecting element or strut on the tube. In some embodiments, forming a pattern on the tube may include laser cutting a pattern on the tube. Representative examples of lasers that may be used include an excimer, carbon dioxide, and YAG. In other embodiments, chemical etching may be used to form a pattern on the tube. It is desirable to use a laser cutting technique which minimizes a size of a heat affected zone. A heat affected zone refers to a region of a target material affected by the heat of the laser. Heat from the laser may tend to melt at least a portion of polymer in the heat affected zone.
  • FIG. 2 depicts a three-dimensional view of an implantable medical device 220 which may be formed from tube 100 in FIG. 1 .
  • FIG. 2 depicts an implantable medical device 150 that includes a pattern of struts 160 .
  • the final etched out pattern should not be limited to what has been illustrated as other stent patterns are easily applicable with the method of the invention.
  • a polymer tube for use in manufacturing an implantable medical device it is desirable for a polymer tube for use in manufacturing an implantable medical device to have adequate strength in the longitudinal direction, as shown by an arrow 135 in FIG. 1 .
  • strength circumferential direction as shown by an arrow 145 in FIG. 1 .
  • a tube with biaxial molecular orientation or equivalently, a tube with a desired degree of molecular orientation in both the longitudinal and the circumferential directions may possess the desirable mechanical properties.
  • Implantable medical devices, such as stents, fabricated from tubes with biaxial orientation may possess mechanical properties similar to or better than metal stents with an acceptable wall thickness and strut width.
  • Polymer tubes may be formed by means of various types of forming methods, including, but not limited to extrusion or injection molding.
  • a polymer tube may be formed from sheets or films that are rolled and bonded.
  • extrusion a polymer melt is conveyed through an extruder which is then formed into a tube.
  • Extrusion tends to impart large forces on the molecules in the longitudinal direction of the tube due to shear forces on the polymer melt. The shear forces arise from forcing the polymer melt through a die and pulling and forming the polymer melt into the small dimensions of a tube.
  • polymer tubes formed by conventional extrusion methods tend to possess a significant degree of longitudinal orientation.
  • conventionally extruded tubes tend to possess no or substantially no orientation in the circumferential direction.
  • forming apparatus such as an extruder.
  • Representative examples of forming apparatuses for the present invention may include single screw extruders, intermeshing co-rotating and counter-rotating twin-screw extruders and other multiple screw masticating extruders.
  • Certain embodiments of manufacturing an implantable medical device with a forming apparatus may include radial expansion of an annular polymer film.
  • a method may include introducing a polymer into a forming apparatus that includes a first annular member disposed within a second annular member.
  • the first annular member may be a mandrel and the second annular member may be a die.
  • the polymer may be conveyed through an annular chamber as an annular film between the annular members.
  • the annular polymer film may be a polymer melt at a temperature above T m of the polymer.
  • the introduced polymer may be at a temperature above a T m of the polymer.
  • the introduced polymer may be at a temperature below a T m of the polymer.
  • the forming apparatus may be configured to melt the polymer.
  • the polymer may be introduced in a mixture that includes the polymer and a solvent. As the mixture is conveyed through the apparatus as an annular film, at least some of the solvent may be vaporized and removed from the apparatus.
  • solvents may include chloroform, acetone, chlorobenzene, ethyl acetate, 1,4-dioxane, ethylene dichloride, 2-ethyhexanol, and combinations thereof.
  • Some embodiments may further include radially expanding the annular film.
  • the annular film may be expanded after exiting from the apparatus.
  • the annular film may be expanded with a gas at a selected pressure. The gas may be conveyed through a second annular chamber within the first annular member. A tube may then be formed from the expanded annular film.
  • the radial expansion may induce circumferential orientation in the annular film, and hence in the resulting tube.
  • the method may further include fabricating an implantable medical device from the tube.
  • the fabricated device may have at least one mechanical property more desirable than an equivalent device fabricated from an equivalent polymer tube formed from an annular film without radial expansion.
  • the dimensions of the polymer tube are equal to dimensions of the equivalent polymer tube formed from an annular film without radial expansion. Additionally, the fabrication of the equivalent device from the equivalent polymer tube is the same as the fabrication of the device from the polymer tube.
  • the induced molecular orientation may result in more desirable mechanical properties such as greater circumferential strength and/or greater rigidity.
  • the radial expansion may be controlled to obtain a desired property of the implantable medical device. For example, the pressure of the gas and the temperature of the annular film influence the radial expansion.
  • the expanded annular film may be drawn to a desired diameter subsequent to radial expansion.
  • the annular film may be drawn by a puller.
  • the puller may include a conveyor assembly that supports and sizes the annular film.
  • the expanded annular film may be cooled during expansion and/or after drawing.
  • the annular film may be conveyed through a water bath at a selected temperature.
  • the annular film may be cooled by air or some other gas at a selected temperature.
  • the cooling rate may be used to control the degree of induced molecular orientation in the polymer tube.
  • the annular film may be cooled at or near an ambient temperature, e.g. 25° C. Alternatively, the annular film may be cooled at a temperature below ambient temperature.
  • the gas used to expand the annular film may be conveyed through a second annular chamber within the first annular member.
  • the gas may be air or some other conveniently available gas.
  • the gas may be an inert gas such as argon, nitrogen, etc.
  • the pressure of the gas may be selected to expand the annular film to a desired inside diameter and outside diameter.
  • the flow of the gas may be configured to expand the annular film to an outer diameter larger than the second annular member and an inner diameter larger than the first annular member.
  • the pressure of the gas may be controlled to obtain a desired property or a desired improvement of a property of the implantable medical device.
  • the drawing speed may also be controlled to obtain a desired degree of induced circumferential orientation. As the drawing speed is increased, the degree of induced circumferential orientation decreases.
  • the temperature of the annular film during expansion is greater than the melting temperature of the polymer. As discussed above, the higher the temperature, the greater the segmental mobility of polymer chains. Therefore, temperature may be used to control the degree of molecular orientation in the annular film, and hence, to obtain desired mechanical properties of the implantable medical device.
  • FIG. 3 illustrates an example of a system and method of manufacturing an implantable medical device that uses radial expansion to induce circumferential molecular orientation.
  • FIG. 3 depicts an axial cross-section of a portion of a forming apparatus 300 .
  • Forming apparatus 300 includes a first annular member 310 , a second annular member 320 , a first annular chamber 330 , and a second annular chamber 340 .
  • Molten polymer in the form of an annular film 350 is conveyed through annular chamber 330 in the direction of arrows 360 .
  • a gas stream 370 at a selected pressure is conveyed through second annular chamber 340 .
  • Annular film 350 is exits from forming apparatus 300 to an expansion region 380 .
  • Annular film 350 is radially expanded by gas 370 as it exits forming apparatus 300 . As shown, annular film 350 is expanded to a diameter greater than the outer diameter of first annular member 310 and the inner diameter of the second annular member 320 . Annular film 350 is then drawn into a cooling region 390 to form a polymer tube 400 .
  • FIG. 3 also depicts an annular film 410 formed without radial expansion. A polymer tube 420 formed from an annular film 410 is also depicted.
  • Certain embodiments of manufacturing an implantable medical device with a forming apparatus may include inducing circumferential orientation by applying shear stress to a polymer.
  • An embodiment of a method for manufacturing an implantable medical device may include introducing a polymer into a forming apparatus with a first annular member disposed within a second annular member.
  • the first annular member may be a mandrel and the second annular member may be a die.
  • the polymer may be conveyed through an annular chamber as an annular film between the annular members.
  • the annular polymer film may be a polymer melt at a temperature above a T m of the polymer.
  • the introduced polymer may be at a temperature above a T m of the polymer.
  • the introduced polymer may be at a temperature below a T m of the polymer.
  • the forming apparatus may be configured to melt the polymer.
  • the polymer may be introduced in a mixture that includes the polymer and a solvent. As the mixture is conveyed through the apparatus as an annular film, at least some of the solvent may be vaporized and removed from the apparatus.
  • the method may further include inducing circumferential flow in the annular film.
  • a polymer tube may be formed from the annular film. It is advantageous for the temperature of the annular film to be greater than the melting temperature of the polymer.
  • the annular film may be removed from the forming apparatus.
  • the induced circumferential flow may induce circumferential orientation in the annular film, and hence in the resulting polymer tube.
  • Some embodiments may then include fabricating an implantable medical device from the polymer tube.
  • a mechanical property of the device may be more desirable than a mechanical property of an equivalent device formed from a polymer tube formed from an annular polymer film formed without circumferential flow.
  • the dimensions of the polymer tube are equal to dimensions of the equivalent polymer tube formed from an annular polymer film formed without circumferential flow.
  • fabrication of the equivalent device from the equivalent polymer tube is the same as the fabrication of the device from the polymer tube.
  • the induced molecular orientation may result in more desirable mechanical properties such as greater circumferential strength and/or greater modulus or rigidity.
  • the circumferential flow may be controlled to obtain a desired property of the implantable medical device.
  • the annular film subjected to circumferential flow may be drawn to a desired diameter.
  • the annular film may also be cooled during expansion and/or after drawing in the manner described above.
  • Various embodiments of a method of inducing circumferential orientation may be distinguished by the manner of inducing circumferential flow.
  • Several embodiments may include inducing circumferential flow in the annular film by rotating the first annular member, the second annular member, or both annular members. It is expected that counter-rotation of both the first annular member and the second annular member may induce the greatest shear on the annular film, and hence, induce the greatest circumferential orientation.
  • the degree of induced orientation may be controlled by parameters such as the rotation speed and relative rotation speed of the annular members.
  • circumferential flow may be induced by a spiral channel on at least a portion of a surface of the rotating first annular member and/or the rotating second annular member.
  • the spiral channel may tend to induce spiral circumferential molecular orientation in the annular polymer film.
  • drawing the annular film may influence the induced circumferential molecular orientation.
  • the annular polymer film is exposed to air at ambient temperature while it is being drawn.
  • the cooling may cause dissipation in molecular orientation in the annular film. Therefore, the length of a drawing region may be directly proportional to a cooling rate of an annular film, and hence, the dissipation of molecular orientation.
  • the rotational speed of annular member(s) may compensate for the dissipation in molecular orientation due to cooling.
  • the rotational speed of annular members(s) is limited since the annular members may become unstable at sufficiently high rotation speeds.
  • FIGS. 4A and 4B illustrate an example of a system and method of manufacturing an implantable medical device that uses circumferential flow to induce molecular orientation.
  • FIG. 4A includes a radial cross-section of a forming apparatus 500 and FIG. 4B includes an axial cross-section of a portion of forming apparatus 500 .
  • Forming apparatus 500 includes a first annular member 510 , a second annular member 520 , a first annular chamber 530 , and a second annular chamber 540 .
  • first annular member 510 and second annular member 520 are configured to rotate as depicted by arrows 515 and 525 , respectively.
  • FIG. 4A first annular member 510 and second annular member 520 are configured to rotate as depicted by arrows 515 and 525 , respectively.
  • annular film 550 shows that molten polymer in the form of an annular film 550 is conveyed through annular chamber 530 in the direction of arrows 560 .
  • Rotation of first annular member 510 and/or second annular member 520 induce circumferential flow in annular film 550 .
  • Annular film 550 is removed from forming apparatus 500 to a drawing region 580 .
  • annular film 550 is drawn to a desired diameter smaller than the diameter of second annular member 520 .
  • Annular film 550 is then drawn into a cooling region 590 to form a polymer tube 595 .
  • circumferential flow may be induced in the annular film with at least a portion of the annular film external to the apparatus.
  • the annular film external to the apparatus may be positioned over or within a third annular member.
  • the third annular member may be configured to rotate at least a portion of the annular film external apparatus.
  • the annular film may exit the forming apparatus and be drawn over or within the third annular member being formed into the polymer tube.
  • the rotating portion of the annular film may induce circumferential flow, and hence, circumferential molecular orientation in the annular film from at least a point of exit from the forming apparatus to the rotating third annular member.
  • the degree of induced orientation may be controlled by the rotation speed of the third annular member.
  • circumferential flow may be induced in at least a portion of the annular film external to the apparatus with at least a portion of the first annular member that is external to the apparatus. Rotation of the first annular member induces circumferential flow to at least a portion of the annular film external to the apparatus.
  • FIG. 5 illustrates another example of a system and method with induced circumferential flow similar to the system and method depicted in FIGS. 4A and 4B .
  • FIG. 5 also depicts an axial cross-section of a portion of a forming apparatus 600 , similar to forming apparatus 500 in FIGS. 4A and 4B .
  • the system in FIG. 5 further includes a third annular member 685 .
  • An annular film 650 is exits from forming apparatus 600 to a drawing region 680 .
  • Annular film 650 is then positioned within third annular member 685 .
  • Third annular member 685 is configured to rotate, as shown by an arrow 687 .
  • Rotation of third annular member 685 induces circumferential flow on the portion of annular film 650 positioned on third annular member 685 .
  • Rotation of the portion of annular film 650 induces circumferential flow on the portion of annular film 650 at least in drawing region 680 .
  • annular film 650 is drawn further into a cooling region 690 to form a polymer tube 695 .
  • First annular member 610 and/or second annular member 620 may also be configured to rotate. Rotation of first annular member 610 and/or second annular member 620 may induce circumferential flow in annular film 650 within forming apparatus 600 .
  • FIG. 6 illustrates another example of a system and method with induced circumferential flow similar to the system and method depicted in FIG. 5 .
  • FIG. 6 also depicts an axial cross-section of a portion of a forming apparatus 700 , similar to forming apparatus 600 in FIG. 5 .
  • the system in FIG. 5 includes a first annular member 710 that extends axially external to forming apparatus 700 .
  • An annular film 750 is exits from forming apparatus 700 to a drawing region 780 .
  • Annular film 750 is then positioned within a third annular member 785 .
  • Third annular member 785 is configured to rotate, as shown by an arrow 787 .
  • Rotation of third annular member 785 induces circumferential flow on the portion of annular film 750 positioned on third annular member 785 .
  • Rotation of the portion of annular film 750 induces circumferential flow on the portion of annular film 750 at least in a drawing region 780 .
  • annular film 750 is drawn further into a cooling region 790 to form polymer tube 795 .
  • First annular member 710 and/or second annular member 720 may also be configured to rotate. Rotation of first annular member 710 may induce circumferential flow in annular film 750 within forming apparatus 700 and within drawing region 780 .
  • Rotation of annular member 720 may induce circumferential flow in annular film 750 within forming apparatus 700 .
  • circumferential flow in the annular film may be induced by rotating the polymer tube.
  • the polymer tube may be rotated by positioning the polymer tube over or within a third annular member that is configured to rotate the polymer tube.
  • the annular film may be cooled to form the polymer tube.
  • the rotating polymer tube may induce circumferential flow, and hence, circumferential orientation in the annular film from the polymer tube to at least the point of exit of the annular film from the apparatus.
  • FIG. 7 illustrates another example of a system and method with induced circumferential flow similar to the system and method depicted in FIGS. 4-6 .
  • FIG. 7 also depicts an axial cross-section of a portion of a forming apparatus 800 , similar, for example, to forming apparatus 500 in FIG. 4B .
  • the system in FIG. 7 includes a fourth annular member 805 .
  • An annular film 850 is exits from forming apparatus 800 to a drawing region 880 .
  • annular film 850 is drawn into a cooling region 890 to form a polymer tube 895 .
  • Polymer tube 895 is positioned on fourth annular member 805 .
  • Fourth annular member 805 is configured to rotate, as shown by an arrow 807 .
  • Fourth annular member 805 rotates polymer tube 895 which induces circumferential flow on the portion of annular film 850 at least in drawing region 880 .
  • First annular member 810 and/or second annular member 820 may also be configured to rotate to induce circumferential flow.
  • some embodiments that include inducing circumferential orientation in a method of manufacturing implantable medical devices may include application of stress to a polymer at temperatures less than or equal to a T m of the polymer.
  • circumferential molecular orientation in a polymer tube may be induced after fabrication of a tube.
  • Certain embodiments of a method of manufacturing an implantable medical device may include radially expanding a tube about a cylindrical axis of the tube from a first diameter to a second diameter. Some embodiments may include expanding a polymer tube plastically beyond the yield point or elastic limit of the polymer. The radial expansion of the polymer tube may induce circumferential molecular orientation, and hence, desired circumferential strength and modulus or rigidity in the polymer tube. As indicated above, a polymer expanded beyond its yield point tends to retain its expanded configuration, and hence, tends to retain the induced molecular orientation. An implantable medical device may then be fabricated from the expanded tube having a second diameter which is greater than the first diameter. An implantable medical device may then be fabricated from the expanded tube having a second diameter greater than the first diameter.
  • the tube may be expanded radially by application of radial pressure. It may be desirable apply a pressure less than about an ultimate stress of the polymer to inhibit or prevent damage to the tube.
  • radial pressure may be applied to the polymer tube by positioning the tube within an annular member and conveying a gas at a selected pressure into a proximal end of the polymer tube. A distal end of the polymer tube may be closed. The end may be open in subsequent manufacturing steps.
  • the annular member may act to control the diameter of the expanded tube by limiting the expansion to the inside diameter of the annular member.
  • the insider diameter of the annular member may correspond to a desired diameter of the tube.
  • the pressure of the conveyed gas may be used to control the expansion of the tube to a desired diameter.
  • Some embodiments may include applying heat to the tube to facilitate radial expansion of the tube.
  • the tube may be heated prior to, contemporaneously with, and/or subsequent to applying radial pressure to the tube.
  • the tube may be heated by conveying a gas at a temperature greater than an ambient temperature on and/or into the tube.
  • Some embodiments may include cooling the expanded tube prior to fabrication of the medical device.
  • the expanded tube may be cooled at a temperature below an ambient temperature.
  • cooling the expanded polymer tube may include cooling the expanded polymer tube at a temperature at or near an ambient temperature.
  • the device may include at least one mechanical property more desirable than an equivalent device fabricated from an equivalent polymer tube formed without radial expansion.
  • the dimensions of the expanded polymer tube are equal to dimensions of the equivalent polymer tube formed without radial expansion.
  • fabrication of the equivalent device from the equivalent polymer tube is the same as the fabrication of the device from the cooled polymer tube.
  • Certain embodiments may include expanding the polymer tube at a temperature below a T g of the polymer.
  • Other embodiments may include expanding the polymer tube in a temperature range greater than or equal to a T g of the polymer and less than or equal to a T m of the polymer. Below T m , the polymer tube may retain its cylindrical shape even with applied pressure.
  • the radial expansion may be controlled to obtain a desired degree of induced molecular orientation, and hence, a desired property of the implantable medical device.
  • the applied pressure, temperature of the polymer tube, and the cooling rate of the polymer tube may be controlled to obtain desired properties, such as circumferential strength and/or modulus or rigidity, of the expanded polymer tube.
  • FIGS. 8A and 8B illustrate a method of expanding a polymer tube for use in manufacturing an implantable medical device.
  • FIG. 8A depicts an axial cross-section of a polymer tube 900 with an outside diameter 905 positioned within an annular member 910 .
  • Annular member 910 may act as a mold that limits the expansion of polymer tube 900 to a diameter 915 , the inside diameter of annular member 910 .
  • Polymer tube 900 may be closed at a distal end 920 .
  • Distal end 920 may be open in subsequent manufacturing steps.
  • a gas such as air or an inert gas, may be conveyed, as indicated by an arrow 925 , into an open proximal end 930 of polymer tube 900 .
  • Polymer tube 900 may be heated by heating the gas to a temperature above ambient temperature prior to conveying the gas into polymer tube 900 .
  • heat may be applied to the exterior of annular member 910 .
  • the conveyed gas combined with the applied heat may act to radially expand polymer tube 900 , as indicated by an arrow 935 .
  • FIG. 8B depicts polymer tube 900 in an expanded state with an outside diameter 940 within annular member 910 .
  • implantable medical devices may be fabricated from tubes that are formed from planar polymer films or sheets.
  • a “film” or “sheet” refers to something that is thin in comparison to its length and breadth.
  • a tube may be formed from a film by rolling a film into a cylindrical shape. The sheet may then be bonded with a suitable adhesive. The film may be bonded at opposing edges of the film that are parallel or substantially parallel to a cylindrical axis. The film may be cut so that the formed tube is a desired diameter.
  • Polymer films or sheets may be made by several different processes.
  • a blown film or sheet can be made by expansion and stretching of a preform or parison.
  • the preform or parison refers to a hollow molten tube extruded from the die head of a blow molding machine expanded within the mold. In the blow molding process, air is blown into the parison and it forms a bubble. The bubble is then drawn through rollers, which stretch the film or sheet to the appropriate thickness.
  • a polymer film may also be made by extrusion through a slit die, such as compression molding.
  • cast film may be made from a cast-film or chill-roll extrusion process.
  • a polymer film with a desired degree of biaxial molecular orientation may be fabricated from blown, cast, or extruded film using biaxial stretching.
  • Certain embodiments of a method of manufacturing an implantable medical device may include stretching a film along a first axis of stretching.
  • the method may further include stretching the film along a second axis of stretching.
  • the film may be stretched by application of a tensile force or drawing tension. The stretching of the film may induce molecular orientation in the polymer film, and hence high strength and modulus or rigidity, along the first axis of stretching and the second axis of stretching.
  • Certain embodiments may include fabricating an implantable medical device from the stretched film.
  • fabricating an implantable medical device from the stretched film may include forming a tube from the stretched film.
  • Some embodiments of fabricating an implantable medical device from the stretched film may include forming a pattern having at least one strut on at least a portion of the tube.
  • a pattern may be formed on the stretched film prior to forming a tube from the stretched sheet.
  • a mechanical property of the device may be more desirable than a mechanical property of an equivalent device fabricated from an unstretched film.
  • the dimensions of the device are equal to dimensions of the equivalent device formed from an unstretched polymer film.
  • the fabrication of the equivalent device is the same as the fabrication of the device.
  • the stretching may be controlled to obtain a desired degree of induced molecular orientation, and hence, desired properties of the implantable medical device.
  • the stretching may be controlled by controlling various process parameters such as tensile force used for stretching, the relative values of the tensile force applied along the axes, and the temperature of the film during stretching.
  • a polymer film may be stretched using a tenter.
  • stretching is performed inside of a box that may be temperature-controlled.
  • a film is grasped on either side by tenterhooks that exert a tensile force or drawing tension along at least one axis.
  • the degree of stretching along the axes may be substantially equal, or alternatively, unbalanced. Therefore, the mechanical properties of a polymer tube formed from a stretched film may be controlled by the degree of stretching along each axis and also by the relative amount stretching along the axes.
  • a tube may be formed to have a desired relative orientation of a cylindrical axis of the tube with at least one stretching axis.
  • a cylindrical axis of a tube formed from the stretched sheet may be parallel, perpendicular, or at an angle between parallel and perpendicular to the first axis of stretching and/or the second axis of stretching.
  • FIG. 9 depicts an x-y coordinate plane 942 for illustrating the relationship between an axis of stretching 944 and a cylindrical axis 946 of a tube formed from a stretched sheet.
  • An angle 948 is the relative orientation between axis of stretching 944 and cylindrical axis 946 .
  • FIG. 10A illustrates a polymer film 950 that has been stretched along two axes indicated by arrows 955 and 960 to have biaxial molecular orientation.
  • FIG. 10B depicts a polymer tube 975 formed from polymer film 950 .
  • Polymer tube 975 is formed so that the axes depicted by arrows 955 and 960 in FIG. 10A are along the radial direction and cylindrical axis of polymer tube 975 , respectively.
  • the film may be stretched plastically beyond the yield point or elastic limit of the polymer along the first axis of stretching and/or the second axis of stretching. However, it may be desirable to stretch with a force that applies a stress that is less than an ultimate stress of the polymer to inhibit or prevent damage to the film.
  • the polymer tube may be stretched elastically. After stretching, an elastically stretched film may be cooled relatively quickly to inhibit contraction and dissipation of induced molecular orientation.
  • the stretched film may be cooled at a temperature substantially below an ambient temperature.
  • a polymer film may be stretched at a temperature greater than or equal to a T g and less than or equal to a T m of the polymer. Below a T m , a planar polymer film may retain its shape even with applied tensile force or tension. In another embodiment, the film may be stretched at a temperature less than or equal to a T g of the polymer. Additionally, the temperature of the film may be controlled to obtain desired properties, such as circumferential strength and/or modulus or rigidity, of a polymer tube formed from the stretched film.

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Manufacturing & Machinery (AREA)
  • Mechanical Engineering (AREA)
  • Surgery (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Materials For Medical Uses (AREA)
  • Prostheses (AREA)
  • Extrusion Moulding Of Plastics Or The Like (AREA)
US10/899,948 2004-07-26 2004-07-26 Method of fabricating an implantable medical device with biaxially oriented polymers Abandoned US20060020330A1 (en)

Priority Applications (11)

Application Number Priority Date Filing Date Title
US10/899,948 US20060020330A1 (en) 2004-07-26 2004-07-26 Method of fabricating an implantable medical device with biaxially oriented polymers
JP2007523649A JP4782121B2 (ja) 2004-07-26 2005-07-20 ２軸配向ポリマーを用いた埋め込み型医療機器の製造方法
EP05773427.9A EP1773566B1 (fr) 2004-07-26 2005-07-20 Procede de production d'un dispositif medical implantable ayant des polymeres a orientation biaxiale
PCT/US2005/025759 WO2006014747A1 (fr) 2004-07-26 2005-07-20 Procede de production d'un dispositif medical implantable ayant des polymeres a orientation biaxiale
US12/806,785 US8192678B2 (en) 2004-07-26 2010-08-19 Method of fabricating an implantable medical device with biaxially oriented polymers
US13/463,562 US8715564B2 (en) 2004-07-26 2012-05-03 Method of fabricating an implantable medical device with biaxially oriented polymers
US13/998,194 US20140107761A1 (en) 2004-07-26 2013-10-09 Biodegradable stent with enhanced fracture toughness
US13/998,195 US20140128959A1 (en) 2004-07-26 2013-10-09 Biodegradable stent with enhanced fracture toughness
US13/998,199 US9517149B2 (en) 2004-07-26 2013-10-09 Biodegradable stent with enhanced fracture toughness
US13/998,204 US20140114394A1 (en) 2004-07-26 2013-10-09 Biodegradable stent with enhanced fracture toughness
US14/252,708 US20140228929A1 (en) 2004-07-26 2014-04-14 Implantable medical device with biaxially oriented polymers

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US10/899,948 US20060020330A1 (en) 2004-07-26 2004-07-26 Method of fabricating an implantable medical device with biaxially oriented polymers

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US11/444,596 Continuation-In-Part US8747879B2 (en) 2004-07-26 2006-05-31 Method of fabricating an implantable medical device to reduce chance of late inflammatory response

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US12/806,785 Division US8192678B2 (en) 2004-07-26 2010-08-19 Method of fabricating an implantable medical device with biaxially oriented polymers

Publications (1)

Publication Number Publication Date
US20060020330A1 true US20060020330A1 (en) 2006-01-26

Family

ID=35385038

Family Applications (4)

Application Number Title Priority Date Filing Date
US10/899,948 Abandoned US20060020330A1 (en) 2004-07-26 2004-07-26 Method of fabricating an implantable medical device with biaxially oriented polymers
US12/806,785 Expired - Fee Related US8192678B2 (en) 2004-07-26 2010-08-19 Method of fabricating an implantable medical device with biaxially oriented polymers
US13/463,562 Expired - Fee Related US8715564B2 (en) 2004-07-26 2012-05-03 Method of fabricating an implantable medical device with biaxially oriented polymers
US14/252,708 Abandoned US20140228929A1 (en) 2004-07-26 2014-04-14 Implantable medical device with biaxially oriented polymers

Family Applications After (3)

Application Number Title Priority Date Filing Date
US12/806,785 Expired - Fee Related US8192678B2 (en) 2004-07-26 2010-08-19 Method of fabricating an implantable medical device with biaxially oriented polymers
US13/463,562 Expired - Fee Related US8715564B2 (en) 2004-07-26 2012-05-03 Method of fabricating an implantable medical device with biaxially oriented polymers
US14/252,708 Abandoned US20140228929A1 (en) 2004-07-26 2014-04-14 Implantable medical device with biaxially oriented polymers

Country Status (4)

Country Link
US (4) US20060020330A1 (fr)
EP (1) EP1773566B1 (fr)
JP (1) JP4782121B2 (fr)
WO (1) WO2006014747A1 (fr)

Cited By (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060076708A1 (en) * 2004-09-30 2006-04-13 Bin Huang Method of fabricating a biaxially oriented implantable medical device
US20070134289A1 (en) * 2005-12-13 2007-06-14 Robert Burgermeister Polymeric stent having modified molecular structures
US20070158880A1 (en) * 2006-01-06 2007-07-12 Vipul Bhupendra Dave Methods of making bioabsorbable drug delivery devices comprised of solvent cast tubes
US20070162110A1 (en) * 2006-01-06 2007-07-12 Vipul Bhupendra Dave Bioabsorbable drug delivery devices
US20070160672A1 (en) * 2006-01-06 2007-07-12 Vipul Bhupendra Dave Methods of making bioabsorbable drug delivery devices comprised of solvent cast films
US20070283552A1 (en) * 2006-05-30 2007-12-13 Gale David C Manufacturing process for polymeric stents
US20070290412A1 (en) * 2006-06-19 2007-12-20 John Capek Fabricating a stent with selected properties in the radial and axial directions
US20070293938A1 (en) * 2006-06-15 2007-12-20 Gale David C Methods of fabricating stents with enhanced fracture toughness
US20080001333A1 (en) * 2006-06-30 2008-01-03 Klaus Kleine Method of fabricating a stent with features by blow molding
US20080046068A1 (en) * 2006-05-12 2008-02-21 Robert Burgermeister Balloon expandable bioabsorbable drug eluting flexible stent
US20080097620A1 (en) * 2006-05-26 2008-04-24 Nanyang Technological University Implantable article, method of forming same and method for reducing thrombogenicity
US20080132995A1 (en) * 2006-05-12 2008-06-05 Robert Burgermeister Balloon expandable bioabsorbable drug eluting stent
US20080147164A1 (en) * 2006-12-13 2008-06-19 Gale David C Optimizing fracture toughness of polymeric stent
WO2008137821A1 (fr) * 2007-05-04 2008-11-13 Abbott Cardiovascular System Inc. Endoprothèses vasculaires à haute résistance radiale, et leur procédé de fabrication
US20090001633A1 (en) * 2007-06-29 2009-01-01 Limon Timothy A Method Of Manufacturing A Stent From A Polymer Tube
US20090012598A1 (en) * 2004-06-29 2009-01-08 Abbate Anthony J Method of fabricating an implantable medical device by deformation of a tube or a sheet
US20090146348A1 (en) * 2007-12-11 2009-06-11 Bin Huang Method of fabrication a stent from blow molded tubing
WO2009076350A1 (fr) 2007-12-11 2009-06-18 Abbott Cardiovascular Systems Inc. Procédé de fabrication d'endoprothèse vasculaire à partir d'un tubage moulé par soufflage
US20090163989A1 (en) * 2007-12-19 2009-06-25 Contiliano Joseph H Balloon expandable bioabsorbable stent with a single stress concentration region interconnecting adjacent struts
US20090248147A1 (en) * 2008-03-31 2009-10-01 Yunbing Wang Stent With Nucleating Agent
US20100025894A1 (en) * 2008-08-04 2010-02-04 Abbott Cardiovascular Inc. Tube expansion process for semicrystalline polymers to maximize fracture toughness
US7770467B1 (en) 2008-08-04 2010-08-10 Abbott Cardiovascular Systems Inc. Fixture for mechanical analysis of a hollow tube
US20100244304A1 (en) * 2009-03-31 2010-09-30 Yunbing Wang Stents fabricated from a sheet with increased strength, modulus and fracture toughness
US20100274349A1 (en) * 2007-05-04 2010-10-28 Brenna Hearn Lord Stents with High Radial Strength and Methods of Manufacturing Same
US20110049751A1 (en) * 2009-08-28 2011-03-03 Abbott Cardiovascular Systems Inc. Method Of Fabricating A Low Crystallinity Poly(L-Lactide) Tube
US20110066222A1 (en) * 2009-09-11 2011-03-17 Yunbing Wang Polymeric Stent and Method of Making Same
US20110062638A1 (en) * 2009-09-14 2011-03-17 Thierry Glauser Controlling Crystalline Morphology Of A Bioabsorbable Stent
US20110079941A1 (en) * 2004-07-26 2011-04-07 Bin Huang Method of fabricating an implantable medical device with biaxially oriented polymers
US8043553B1 (en) 2004-09-30 2011-10-25 Advanced Cardiovascular Systems, Inc. Controlled deformation of a polymer tube with a restraining surface in fabricating a medical article
US8173062B1 (en) 2004-09-30 2012-05-08 Advanced Cardiovascular Systems, Inc. Controlled deformation of a polymer tube in fabricating a medical article
US20120280432A1 (en) * 2011-05-06 2012-11-08 Industrial Technology Research Institute Method for manufacturing bioabsorbable stents
US8370120B2 (en) 2010-04-30 2013-02-05 Abbott Cardiovascular Systems Inc. Polymeric stents and method of manufacturing same
US8388673B2 (en) 2008-05-02 2013-03-05 Abbott Cardiovascular Systems Inc. Polymeric stent
US20140114398A1 (en) * 2012-10-23 2014-04-24 Abbott Cardiovascular Systems Inc. Time-dependent polymer scaffolds
US8747728B2 (en) 2011-05-24 2014-06-10 Abbott Cardiovascular Systems Inc. Method and system for manufacturing a polymer endoprosthesis by injection molding and blow molding
US8778256B1 (en) 2004-09-30 2014-07-15 Advanced Cardiovascular Systems, Inc. Deformation of a polymer tube in the fabrication of a medical article
GB2512016A (en) * 2012-09-24 2014-09-24 Arterius Ltd Methods
US9198785B2 (en) 2010-01-30 2015-12-01 Abbott Cardiovascular Systems Inc. Crush recoverable polymer scaffolds
US9216238B2 (en) 2006-04-28 2015-12-22 Abbott Cardiovascular Systems Inc. Implantable medical device having reduced chance of late inflammatory response
US9364588B2 (en) 2014-02-04 2016-06-14 Abbott Cardiovascular Systems Inc. Drug delivery scaffold or stent with a novolimus and lactide based coating such that novolimus has a minimum amount of bonding to the coating
US9517149B2 (en) 2004-07-26 2016-12-13 Abbott Cardiovascular Systems Inc. Biodegradable stent with enhanced fracture toughness
US9827119B2 (en) 2010-01-30 2017-11-28 Abbott Cardiovascular Systems Inc. Polymer scaffolds having a low crossing profile
US9908143B2 (en) 2008-06-20 2018-03-06 Amaranth Medical Pte. Stent fabrication via tubular casting processes
US10307274B2 (en) 2011-07-29 2019-06-04 Abbott Cardiovascular Systems Inc. Methods for uniform crimping and deployment of a polymer scaffold
US10646359B2 (en) 2008-06-20 2020-05-12 Amaranth Medical Pte. Stent fabrication via tubular casting processes
CN114101472A (zh) * 2021-11-30 2022-03-01 内蒙古工业大学 一种铝合金蠕变时效成型设备
US11931484B2 (en) 2008-06-20 2024-03-19 Razmodics Llc Composite stent having multi-axial flexibility and method of manufacture thereof

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101747876B (zh) * 2008-12-16 2013-07-24 西部钻探克拉玛依钻井工艺研究院 一种碳酸钾聚胺钻井液
CN102167836B (zh) * 2011-03-01 2012-11-14 宜兴市高拓高分子材料有限公司 一种聚偏氟乙烯薄膜的制备方法
US10022906B2 (en) * 2014-07-30 2018-07-17 Abbott Cardiovascular Systems Inc. Methods for solid phase processing of tubes and medical devices made from the processed tubes
US9381103B2 (en) 2014-10-06 2016-07-05 Abbott Cardiovascular Systems Inc. Stent with elongating struts
EP3760411A1 (fr) * 2019-07-02 2021-01-06 Biotronik Ag Procédé de modification d'une surface d'un ballonnet pour un cathéter à ballonnet

Citations (96)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3636956A (en) * 1970-05-13 1972-01-25 Ethicon Inc Polylactide sutures
US4633873A (en) * 1984-04-26 1987-01-06 American Cyanamid Company Surgical repair mesh
US4656083A (en) * 1983-08-01 1987-04-07 Washington Research Foundation Plasma gas discharge treatment for improving the biocompatibility of biomaterials
US4718907A (en) * 1985-06-20 1988-01-12 Atrium Medical Corporation Vascular prosthesis having fluorinated coating with varying F/C ratio
US4722335A (en) * 1986-10-20 1988-02-02 Vilasi Joseph A Expandable endotracheal tube
US4723549A (en) * 1986-09-18 1988-02-09 Wholey Mark H Method and apparatus for dilating blood vessels
US4732152A (en) * 1984-12-05 1988-03-22 Medinvent S.A. Device for implantation and a method of implantation in a vessel using such device
US4733665A (en) * 1985-11-07 1988-03-29 Expandable Grafts Partnership Expandable intraluminal graft, and method and apparatus for implanting an expandable intraluminal graft
US4740207A (en) * 1986-09-10 1988-04-26 Kreamer Jeffry W Intralumenal graft
US4800882A (en) * 1987-03-13 1989-01-31 Cook Incorporated Endovascular stent and delivery system
US4816339A (en) * 1987-04-28 1989-03-28 Baxter International Inc. Multi-layered poly(tetrafluoroethylene)/elastomer materials useful for in vivo implantation
US4818559A (en) * 1985-08-08 1989-04-04 Sumitomo Chemical Company, Limited Method for producing endosseous implants
US4902289A (en) * 1982-04-19 1990-02-20 Massachusetts Institute Of Technology Multilayer bioreplaceable blood vessel prosthesis
US4987025A (en) * 1985-08-12 1991-01-22 Mitsui Petrochemical Industries, Ltd. Inflation film of ultrahigh molecular weight polyethylene
US4994289A (en) * 1987-08-31 1991-02-19 Yu Qi Hai Aging of alcoholic beverages
US5084065A (en) * 1989-07-10 1992-01-28 Corvita Corporation Reinforced graft assembly
US5085629A (en) * 1988-10-06 1992-02-04 Medical Engineering Corporation Biodegradable stent
US5087394A (en) * 1989-11-09 1992-02-11 Scimed Life Systems, Inc. Method for forming an inflatable balloon for use in a catheter
US5100429A (en) * 1989-04-28 1992-03-31 C. R. Bard, Inc. Endovascular stent and delivery system
US5104410A (en) * 1990-10-22 1992-04-14 Intermedics Orthopedics, Inc Surgical implant having multiple layers of sintered porous coating and method
US5108416A (en) * 1990-02-13 1992-04-28 C. R. Bard, Inc. Stent introducer system
US5192311A (en) * 1988-04-25 1993-03-09 Angeion Corporation Medical implant and method of making
US5197977A (en) * 1984-01-30 1993-03-30 Meadox Medicals, Inc. Drug delivery collagen-impregnated synthetic vascular graft
US5279594A (en) * 1990-05-23 1994-01-18 Jackson Richard R Intubation devices with local anesthetic effect for medical use
US5282860A (en) * 1991-10-16 1994-02-01 Olympus Optical Co., Ltd. Stent tube for medical use
US5290271A (en) * 1990-05-14 1994-03-01 Jernberg Gary R Surgical implant and method for controlled release of chemotherapeutic agents
US5289831A (en) * 1989-03-09 1994-03-01 Vance Products Incorporated Surface-treated stent, catheter, cannula, and the like
US5383925A (en) * 1992-09-14 1995-01-24 Meadox Medicals, Inc. Three-dimensional braided soft tissue prosthesis
US5385580A (en) * 1990-08-28 1995-01-31 Meadox Medicals, Inc. Self-supporting woven vascular graft
US5389106A (en) * 1993-10-29 1995-02-14 Numed, Inc. Impermeable expandable intravascular stent
US5399666A (en) * 1994-04-21 1995-03-21 E. I. Du Pont De Nemours And Company Easily degradable star-block copolymers
US5500013A (en) * 1991-10-04 1996-03-19 Scimed Life Systems, Inc. Biodegradable drug delivery vascular stent
US5502158A (en) * 1988-08-08 1996-03-26 Ecopol, Llc Degradable polymer composition
US5591199A (en) * 1995-06-07 1997-01-07 Porter; Christopher H. Curable fiber composite stent and delivery system
US5591607A (en) * 1994-03-18 1997-01-07 Lynx Therapeutics, Inc. Oligonucleotide N3→P5' phosphoramidates: triplex DNA formation
US5593403A (en) * 1994-09-14 1997-01-14 Scimed Life Systems Inc. Method for modifying a stent in an implanted site
US5593434A (en) * 1992-01-31 1997-01-14 Advanced Cardiovascular Systems, Inc. Stent capable of attachment within a body lumen
US5599301A (en) * 1993-11-22 1997-02-04 Advanced Cardiovascular Systems, Inc. Motor control system for an automatic catheter inflation system
US5605696A (en) * 1995-03-30 1997-02-25 Advanced Cardiovascular Systems, Inc. Drug loaded polymeric material and method of manufacture
US5607442A (en) * 1995-11-13 1997-03-04 Isostent, Inc. Stent with improved radiopacity and appearance characteristics
US5607467A (en) * 1990-09-14 1997-03-04 Froix; Michael Expandable polymeric stent with memory and delivery apparatus and method
US5707385A (en) * 1994-11-16 1998-01-13 Advanced Cardiovascular Systems, Inc. Drug loaded elastic membrane and method for delivery
US5711763A (en) * 1991-02-20 1998-01-27 Tdk Corporation Composite biological implant of a ceramic material in a metal substrate
US5716981A (en) * 1993-07-19 1998-02-10 Angiogenesis Technologies, Inc. Anti-angiogenic compositions and methods of use
US5725549A (en) * 1994-03-11 1998-03-10 Advanced Cardiovascular Systems, Inc. Coiled stent with locking ends
US5726297A (en) * 1994-03-18 1998-03-10 Lynx Therapeutics, Inc. Oligodeoxyribonucleotide N3' P5' phosphoramidates
US5728751A (en) * 1996-11-25 1998-03-17 Meadox Medicals, Inc. Bonding bio-active materials to substrate surfaces
US5733330A (en) * 1997-01-13 1998-03-31 Advanced Cardiovascular Systems, Inc. Balloon-expandable, crush-resistant locking stent
US5733564A (en) * 1993-04-14 1998-03-31 Leiras Oy Method of treating endo-osteal materials with a bisphosphonate solution
US5733326A (en) * 1996-05-28 1998-03-31 Cordis Corporation Composite material endoprosthesis
US5733925A (en) * 1993-01-28 1998-03-31 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US5855612A (en) * 1995-05-12 1999-01-05 Ohta Inc. Biocompatible titanium implant
US5855618A (en) * 1996-09-13 1999-01-05 Meadox Medicals, Inc. Polyurethanes grafted with polyethylene oxide chains containing covalently bonded heparin
US5858746A (en) * 1992-04-20 1999-01-12 Board Of Regents, The University Of Texas System Gels for encapsulation of biological materials
US5865814A (en) * 1995-06-07 1999-02-02 Medtronic, Inc. Blood contacting medical device and method
US5868781A (en) * 1996-10-22 1999-02-09 Scimed Life Systems, Inc. Locking stent
US5874101A (en) * 1997-04-14 1999-02-23 Usbiomaterials Corp. Bioactive-gel compositions and methods
US5874109A (en) * 1994-07-27 1999-02-23 The Trustees Of The University Of Pennsylvania Incorporation of biological molecules into bioactive glasses
US5873904A (en) * 1995-06-07 1999-02-23 Cook Incorporated Silver implantable medical device
US5874165A (en) * 1996-06-03 1999-02-23 Gore Enterprise Holdings, Inc. Materials and method for the immobilization of bioactive species onto polymeric subtrates
US5876743A (en) * 1995-03-21 1999-03-02 Den-Mat Corporation Biocompatible adhesion in tissue repair
US5877263A (en) * 1996-11-25 1999-03-02 Meadox Medicals, Inc. Process for preparing polymer coatings grafted with polyethylene oxide chains containing covalently bonded bio-active agents
US5879713A (en) * 1994-10-12 1999-03-09 Focal, Inc. Targeted delivery via biodegradable polymers
US5888533A (en) * 1995-10-27 1999-03-30 Atrix Laboratories, Inc. Non-polymeric sustained release delivery system
US6010445A (en) * 1997-09-11 2000-01-04 Implant Sciences Corporation Radioactive medical device and process
US6015541A (en) * 1997-11-03 2000-01-18 Micro Therapeutics, Inc. Radioactive embolizing compositions
US6042875A (en) * 1997-04-30 2000-03-28 Schneider (Usa) Inc. Drug-releasing coatings for medical devices
US6171609B1 (en) * 1995-02-15 2001-01-09 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US6174330B1 (en) * 1997-08-01 2001-01-16 Schneider (Usa) Inc Bioabsorbable marker having radiopaque constituents
US6177523B1 (en) * 1999-07-14 2001-01-23 Cardiotech International, Inc. Functionalized polyurethanes
US6183505B1 (en) * 1999-03-11 2001-02-06 Medtronic Ave, Inc. Method of stent retention to a delivery catheter balloon-braided retainers
US6187045B1 (en) * 1999-02-10 2001-02-13 Thomas K. Fehring Enhanced biocompatible implants and alloys
US20020002399A1 (en) * 1999-12-22 2002-01-03 Huxel Shawn Thayer Removable stent for body lumens
US20020004101A1 (en) * 1995-04-19 2002-01-10 Schneider (Usa) Inc. Drug coating with topcoat
US20020004060A1 (en) * 1997-07-18 2002-01-10 Bernd Heublein Metallic implant which is degradable in vivo
US6360577B2 (en) * 1999-09-22 2002-03-26 Scimed Life Systems, Inc. Apparatus for contracting, or crimping stents
US6511748B1 (en) * 1998-01-06 2003-01-28 Aderans Research Institute, Inc. Bioabsorbable fibers and reinforced composites produced therefrom
US20030028246A1 (en) * 1999-11-19 2003-02-06 Palmaz Julio C. Compliant implantable medical devices and methods of making same
US20030028241A1 (en) * 2001-08-02 2003-02-06 Stinson Jonathan Swift Method for enhancing sheet or tubing metal stent radiopacity
US6517888B1 (en) * 2000-11-28 2003-02-11 Scimed Life Systems, Inc. Method for manufacturing a medical device having a coated portion by laser ablation
US20030033001A1 (en) * 2001-02-27 2003-02-13 Keiji Igaki Stent holding member and stent feeding system
US6527801B1 (en) * 2000-04-13 2003-03-04 Advanced Cardiovascular Systems, Inc. Biodegradable drug delivery material for stent
US6537589B1 (en) * 2000-04-03 2003-03-25 Kyung Won Medical Co., Ltd. Calcium phosphate artificial bone as osteoconductive and biodegradable bone substitute material
US20040000361A1 (en) * 2002-06-27 2004-01-01 Thomas Trozera Method of manufacturing an implantable stent having improved mechanical properties
US6676697B1 (en) * 1996-09-19 2004-01-13 Medinol Ltd. Stent with variable features to optimize support and method of making such stent
US6679980B1 (en) * 2001-06-13 2004-01-20 Advanced Cardiovascular Systems, Inc. Apparatus for electropolishing a stent
US6689375B1 (en) * 1999-11-09 2004-02-10 Coripharm Medizinprodukte Gmbh & Co. Kg Resorbable bone implant material and method for producing the same
US6695920B1 (en) * 2001-06-27 2004-02-24 Advanced Cardiovascular Systems, Inc. Mandrel for supporting a stent and a method of using the mandrel to coat a stent
US6706273B1 (en) * 1999-08-14 2004-03-16 Ivoclar Vivadent Ag Composition for implantation into the human and animal body
US6709379B1 (en) * 1998-11-02 2004-03-23 Alcove Surfaces Gmbh Implant with cavities containing therapeutic agents
US20050004663A1 (en) * 2001-05-07 2005-01-06 Llanos Gerard H. Heparin barrier coating for controlled drug release
US6846323B2 (en) * 2003-05-15 2005-01-25 Advanced Cardiovascular Systems, Inc. Intravascular stent
US20080001333A1 (en) * 2006-06-30 2008-01-03 Klaus Kleine Method of fabricating a stent with features by blow molding
US20090005860A1 (en) * 2007-06-27 2009-01-01 Gale David C Method to fabricate a stent having selected morphology to reduce restenosis
US20090001633A1 (en) * 2007-06-29 2009-01-01 Limon Timothy A Method Of Manufacturing A Stent From A Polymer Tube
US20090012598A1 (en) * 2004-06-29 2009-01-08 Abbate Anthony J Method of fabricating an implantable medical device by deformation of a tube or a sheet

Family Cites Families (60)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4136143A (en) * 1977-02-22 1979-01-23 Lupke Gerd Paul Heinrich Apparatus for and method of producing corrugated thermoplastic tubing
GB2089276B (en) 1980-11-19 1984-09-05 Metal Box Co Ltd Thermoplastics tubular articles
JPS5827548A (ja) 1981-07-30 1983-02-18 エチコン・インコ−ポレ−テツド 焼きもどししたポリジオキサノン外科器具及びその製造方法
FR2554386B1 (fr) 1983-11-07 1986-02-07 Plastic Omnium Cie Procede de fabrication de tubes profiles en matiere plastique, dispositif pour la mise en oeuvre de ce procede, et tubes profiles obtenus
JPH0655433B2 (ja) * 1985-08-12 1994-07-27 三井石油化学工業株式会社 インフレ−シヨンフイルム、その製法と装置
US4698196A (en) * 1985-12-24 1987-10-06 Xerox Corporation Method and apparatus for extruding creaseless thin walled tubes
US4702884A (en) 1986-07-03 1987-10-27 The United States Of America As Represented By The Secretary Of The Navy Glass-lined pipes
US5019090A (en) * 1988-09-01 1991-05-28 Corvita Corporation Radially expandable endoprosthesis and the like
US6500146B1 (en) 1988-10-04 2002-12-31 Cordis Corporation Balloons for medical devices and fabrication thereof
US5147302A (en) 1989-04-21 1992-09-15 Scimed Life Systems, Inc. Method of shaping a balloon of a balloon catheter
US5116365A (en) 1991-02-22 1992-05-26 Cordis Corporation Stent apparatus and method for making
AU664913B2 (en) 1992-08-13 1995-12-07 Implico B.V. A hydrogel composition and methods of making it
US5857998A (en) 1994-06-30 1999-01-12 Boston Scientific Corporation Stent and therapeutic delivery system
US5836964A (en) 1996-10-30 1998-11-17 Medinol Ltd. Stent fabrication method
CA2163824C (fr) 1994-11-28 2000-06-20 Richard J. Saunders Methode et appareil pour la coupe directe au laser, d'extenseurs metalliques
US5628786A (en) 1995-05-12 1997-05-13 Impra, Inc. Radially expandable vascular graft with resistance to longitudinal compression and method of making same
US5725547A (en) * 1996-01-04 1998-03-10 Chuter; Timothy A. M. Corrugated stent
ES2208886T3 (es) 1996-03-07 2004-06-16 Med Institute, Inc. Un stent expandible.
US5670161A (en) 1996-05-28 1997-09-23 Healy; Kevin E. Biodegradable stent
US5906759A (en) 1996-12-26 1999-05-25 Medinol Ltd. Stent forming apparatus with stent deforming blades
US5891386A (en) 1997-04-25 1999-04-06 Medtronic, Inc. Method for making catheter balloons
CA2232250C (fr) 1997-05-14 2007-06-26 Navius Corporation Ballonnet pour un catheter de dilatation et methode de fabrication d'un ballonnet
DE19745294A1 (de) * 1997-10-14 1999-04-15 Biotronik Mess & Therapieg Verfahren zur Herstellung feinstrukturierter medizintechnischer Implantate
US6626939B1 (en) 1997-12-18 2003-09-30 Boston Scientific Scimed, Inc. Stent-graft with bioabsorbable structural support
US6015433A (en) * 1998-05-29 2000-01-18 Micro Therapeutics, Inc. Rolled stent with waveform perforation pattern
EP1119379A1 (fr) 1998-09-02 2001-08-01 Boston Scientific Limited Systeme d'administration de medicaments pour stent
KR100617375B1 (ko) 1998-09-08 2006-08-29 가부시키가이샤 이가키 이료 세케이 맥관용 스텐트
US20010014821A1 (en) 1998-11-16 2001-08-16 Mohamad Ike Juman Balloon catheter and stent delivery system having enhanced stent retention
US7637886B2 (en) 1999-01-25 2009-12-29 Atrium Medical Corporation Expandable fluoropolymer device and method of making
WO2001015633A1 (fr) * 1999-09-01 2001-03-08 Scimed Life Systems, Inc. Dispositif composite de greffe d'endoprothese tubulaire et son procede de fabrication
US7226475B2 (en) 1999-11-09 2007-06-05 Boston Scientific Scimed, Inc. Stent with variable properties
US6572813B1 (en) 2000-01-13 2003-06-03 Advanced Cardiovascular Systems, Inc. Balloon forming process
DK2298366T3 (da) 2000-03-13 2012-11-26 Kyoto Iryo Sekkei Kk Lineært materiale til intravaskulær stent og intravaskulær stent med anvendelse deraf
EP1420718A4 (fr) * 2000-09-29 2005-12-28 Endovasc Ltd Inc Prosthese resorbable destinee au traitement medical
WO2003061502A1 (fr) * 2000-10-26 2003-07-31 Scimed Life Systems, Inc. Prothese endovasculaire a marqueurs radio-opaques et son procede de fabrication
US6878790B2 (en) * 2000-11-30 2005-04-12 The Procter & Gamble Company High molecular weight polyolefin and catalyst and process for polymerizing said polyolefin
WO2002055566A2 (fr) * 2000-11-30 2002-07-18 The Procter & Gamble Company Polyolefine de poids moleculaire eleve, catalyseur et procede de polymerisation de ladite polyolefine
US6563080B2 (en) * 2001-02-15 2003-05-13 Scimed Life Systems, Inc. Laser cutting of stents and other medical devices
US20030009151A1 (en) * 2001-07-03 2003-01-09 Scimed Life Systems, Inc. Biaxially oriented multilayer polymer tube for medical devices
US7083639B2 (en) 2001-09-26 2006-08-01 Medtronic Vascular, Inc. Stent delivery catheter with grooved balloon and methods of making same
US7572287B2 (en) 2001-10-25 2009-08-11 Boston Scientific Scimed, Inc. Balloon expandable polymer stent with reduced elastic recoil
US7163655B2 (en) 2002-03-28 2007-01-16 Scimed Life Systems, Inc. Method and apparatus for extruding polymers employing microwave energy
US6948223B2 (en) 2002-05-03 2005-09-27 Medtronic Vascular, Inc. Apparatus for mounting a stent onto a stent delivery system
US20040098090A1 (en) 2002-11-14 2004-05-20 Williams Michael S. Polymeric endoprosthesis and method of manufacture
US20050187615A1 (en) 2004-02-23 2005-08-25 Williams Michael S. Polymeric endoprostheses with enhanced strength and flexibility and methods of manufacture
US7128868B2 (en) 2003-01-10 2006-10-31 Boston Scientific Scimed, Inc. Balloon wing forming apparatus and method
US20050137678A1 (en) 2003-12-22 2005-06-23 Medtronic Vascular, Inc. Low profile resorbable stent
US20050196485A1 (en) 2004-01-13 2005-09-08 Martin Cass Heat transfer system for a mold
US20050177130A1 (en) 2004-02-10 2005-08-11 Angioscore, Inc. Balloon catheter with spiral folds
US8747878B2 (en) 2006-04-28 2014-06-10 Advanced Cardiovascular Systems, Inc. Method of fabricating an implantable medical device by controlling crystalline structure
US8747879B2 (en) 2006-04-28 2014-06-10 Advanced Cardiovascular Systems, Inc. Method of fabricating an implantable medical device to reduce chance of late inflammatory response
US8268228B2 (en) 2007-12-11 2012-09-18 Abbott Cardiovascular Systems Inc. Method of fabricating stents from blow molded tubing
US7731890B2 (en) 2006-06-15 2010-06-08 Advanced Cardiovascular Systems, Inc. Methods of fabricating stents with enhanced fracture toughness
US20060020330A1 (en) 2004-07-26 2006-01-26 Bin Huang Method of fabricating an implantable medical device with biaxially oriented polymers
US7875233B2 (en) 2004-09-30 2011-01-25 Advanced Cardiovascular Systems, Inc. Method of fabricating a biaxially oriented implantable medical device
CA2601136C (fr) 2005-03-18 2011-06-07 Wilson-Cook Medical Inc. Guide-fils dotes de regions de surface exterieures inedites et reservoirs permettant d'ameliorer les proprietes hydrophiles et l'administration d'agents therapeutiques
US20060224226A1 (en) 2005-03-31 2006-10-05 Bin Huang In-vivo radial orientation of a polymeric implantable medical device
US20070135892A1 (en) 2005-12-13 2007-06-14 Robert Burgermeister Polymeric stent having modified molecular structures in the flexible connectors and in the radial struts and the radial arcs of the hoops
US20070282433A1 (en) 2006-06-01 2007-12-06 Limon Timothy A Stent with retention protrusions formed during crimping
US20070290412A1 (en) 2006-06-19 2007-12-20 John Capek Fabricating a stent with selected properties in the radial and axial directions

Patent Citations (102)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3636956A (en) * 1970-05-13 1972-01-25 Ethicon Inc Polylactide sutures
US4902289A (en) * 1982-04-19 1990-02-20 Massachusetts Institute Of Technology Multilayer bioreplaceable blood vessel prosthesis
US4656083A (en) * 1983-08-01 1987-04-07 Washington Research Foundation Plasma gas discharge treatment for improving the biocompatibility of biomaterials
US5197977A (en) * 1984-01-30 1993-03-30 Meadox Medicals, Inc. Drug delivery collagen-impregnated synthetic vascular graft
US4633873A (en) * 1984-04-26 1987-01-06 American Cyanamid Company Surgical repair mesh
US4732152A (en) * 1984-12-05 1988-03-22 Medinvent S.A. Device for implantation and a method of implantation in a vessel using such device
US4718907A (en) * 1985-06-20 1988-01-12 Atrium Medical Corporation Vascular prosthesis having fluorinated coating with varying F/C ratio
US4818559A (en) * 1985-08-08 1989-04-04 Sumitomo Chemical Company, Limited Method for producing endosseous implants
US4987025A (en) * 1985-08-12 1991-01-22 Mitsui Petrochemical Industries, Ltd. Inflation film of ultrahigh molecular weight polyethylene
US4733665A (en) * 1985-11-07 1988-03-29 Expandable Grafts Partnership Expandable intraluminal graft, and method and apparatus for implanting an expandable intraluminal graft
US4733665C2 (en) * 1985-11-07 2002-01-29 Expandable Grafts Partnership Expandable intraluminal graft and method and apparatus for implanting an expandable intraluminal graft
US4739762A (en) * 1985-11-07 1988-04-26 Expandable Grafts Partnership Expandable intraluminal graft, and method and apparatus for implanting an expandable intraluminal graft
US4733665B1 (en) * 1985-11-07 1994-01-11 Expandable Grafts Partnership Expandable intraluminal graft,and method and apparatus for implanting an expandable intraluminal graft
US4739762B1 (en) * 1985-11-07 1998-10-27 Expandable Grafts Partnership Expandable intraluminal graft and method and apparatus for implanting an expandable intraluminal graft
US4740207A (en) * 1986-09-10 1988-04-26 Kreamer Jeffry W Intralumenal graft
US4723549A (en) * 1986-09-18 1988-02-09 Wholey Mark H Method and apparatus for dilating blood vessels
US4722335A (en) * 1986-10-20 1988-02-02 Vilasi Joseph A Expandable endotracheal tube
US4800882A (en) * 1987-03-13 1989-01-31 Cook Incorporated Endovascular stent and delivery system
US4816339A (en) * 1987-04-28 1989-03-28 Baxter International Inc. Multi-layered poly(tetrafluoroethylene)/elastomer materials useful for in vivo implantation
US4994289A (en) * 1987-08-31 1991-02-19 Yu Qi Hai Aging of alcoholic beverages
US5192311A (en) * 1988-04-25 1993-03-09 Angeion Corporation Medical implant and method of making
US5502158A (en) * 1988-08-08 1996-03-26 Ecopol, Llc Degradable polymer composition
US5085629A (en) * 1988-10-06 1992-02-04 Medical Engineering Corporation Biodegradable stent
US5289831A (en) * 1989-03-09 1994-03-01 Vance Products Incorporated Surface-treated stent, catheter, cannula, and the like
US5100429A (en) * 1989-04-28 1992-03-31 C. R. Bard, Inc. Endovascular stent and delivery system
US5084065A (en) * 1989-07-10 1992-01-28 Corvita Corporation Reinforced graft assembly
US5087394A (en) * 1989-11-09 1992-02-11 Scimed Life Systems, Inc. Method for forming an inflatable balloon for use in a catheter
US5108416A (en) * 1990-02-13 1992-04-28 C. R. Bard, Inc. Stent introducer system
US5290271A (en) * 1990-05-14 1994-03-01 Jernberg Gary R Surgical implant and method for controlled release of chemotherapeutic agents
US5279594A (en) * 1990-05-23 1994-01-18 Jackson Richard R Intubation devices with local anesthetic effect for medical use
US5385580A (en) * 1990-08-28 1995-01-31 Meadox Medicals, Inc. Self-supporting woven vascular graft
US5607467A (en) * 1990-09-14 1997-03-04 Froix; Michael Expandable polymeric stent with memory and delivery apparatus and method
US5104410A (en) * 1990-10-22 1992-04-14 Intermedics Orthopedics, Inc Surgical implant having multiple layers of sintered porous coating and method
US5711763A (en) * 1991-02-20 1998-01-27 Tdk Corporation Composite biological implant of a ceramic material in a metal substrate
US5500013A (en) * 1991-10-04 1996-03-19 Scimed Life Systems, Inc. Biodegradable drug delivery vascular stent
US5282860A (en) * 1991-10-16 1994-02-01 Olympus Optical Co., Ltd. Stent tube for medical use
US5593434A (en) * 1992-01-31 1997-01-14 Advanced Cardiovascular Systems, Inc. Stent capable of attachment within a body lumen
US5858746A (en) * 1992-04-20 1999-01-12 Board Of Regents, The University Of Texas System Gels for encapsulation of biological materials
US5383925A (en) * 1992-09-14 1995-01-24 Meadox Medicals, Inc. Three-dimensional braided soft tissue prosthesis
US5733925A (en) * 1993-01-28 1998-03-31 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US5733564A (en) * 1993-04-14 1998-03-31 Leiras Oy Method of treating endo-osteal materials with a bisphosphonate solution
US5716981A (en) * 1993-07-19 1998-02-10 Angiogenesis Technologies, Inc. Anti-angiogenic compositions and methods of use
US5389106A (en) * 1993-10-29 1995-02-14 Numed, Inc. Impermeable expandable intravascular stent
US5599301A (en) * 1993-11-22 1997-02-04 Advanced Cardiovascular Systems, Inc. Motor control system for an automatic catheter inflation system
US5725549A (en) * 1994-03-11 1998-03-10 Advanced Cardiovascular Systems, Inc. Coiled stent with locking ends
US6169170B1 (en) * 1994-03-18 2001-01-02 Lynx Therapeutics, Inc. Oligonucleotide N3′→N5′Phosphoramidate Duplexes
US5599922A (en) * 1994-03-18 1997-02-04 Lynx Therapeutics, Inc. Oligonucleotide N3'-P5' phosphoramidates: hybridization and nuclease resistance properties
US5726297A (en) * 1994-03-18 1998-03-10 Lynx Therapeutics, Inc. Oligodeoxyribonucleotide N3' P5' phosphoramidates
US5591607A (en) * 1994-03-18 1997-01-07 Lynx Therapeutics, Inc. Oligonucleotide N3→P5' phosphoramidates: triplex DNA formation
US5399666A (en) * 1994-04-21 1995-03-21 E. I. Du Pont De Nemours And Company Easily degradable star-block copolymers
US5874109A (en) * 1994-07-27 1999-02-23 The Trustees Of The University Of Pennsylvania Incorporation of biological molecules into bioactive glasses
US5593403A (en) * 1994-09-14 1997-01-14 Scimed Life Systems Inc. Method for modifying a stent in an implanted site
US5879713A (en) * 1994-10-12 1999-03-09 Focal, Inc. Targeted delivery via biodegradable polymers
US5707385A (en) * 1994-11-16 1998-01-13 Advanced Cardiovascular Systems, Inc. Drug loaded elastic membrane and method for delivery
US6171609B1 (en) * 1995-02-15 2001-01-09 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US5876743A (en) * 1995-03-21 1999-03-02 Den-Mat Corporation Biocompatible adhesion in tissue repair
US5605696A (en) * 1995-03-30 1997-02-25 Advanced Cardiovascular Systems, Inc. Drug loaded polymeric material and method of manufacture
US20020004101A1 (en) * 1995-04-19 2002-01-10 Schneider (Usa) Inc. Drug coating with topcoat
US5855612A (en) * 1995-05-12 1999-01-05 Ohta Inc. Biocompatible titanium implant
US5865814A (en) * 1995-06-07 1999-02-02 Medtronic, Inc. Blood contacting medical device and method
US5591199A (en) * 1995-06-07 1997-01-07 Porter; Christopher H. Curable fiber composite stent and delivery system
US5873904A (en) * 1995-06-07 1999-02-23 Cook Incorporated Silver implantable medical device
US5888533A (en) * 1995-10-27 1999-03-30 Atrix Laboratories, Inc. Non-polymeric sustained release delivery system
US5607442A (en) * 1995-11-13 1997-03-04 Isostent, Inc. Stent with improved radiopacity and appearance characteristics
US5733326A (en) * 1996-05-28 1998-03-31 Cordis Corporation Composite material endoprosthesis
US5874165A (en) * 1996-06-03 1999-02-23 Gore Enterprise Holdings, Inc. Materials and method for the immobilization of bioactive species onto polymeric subtrates
US5855618A (en) * 1996-09-13 1999-01-05 Meadox Medicals, Inc. Polyurethanes grafted with polyethylene oxide chains containing covalently bonded heparin
US6676697B1 (en) * 1996-09-19 2004-01-13 Medinol Ltd. Stent with variable features to optimize support and method of making such stent
US5868781A (en) * 1996-10-22 1999-02-09 Scimed Life Systems, Inc. Locking stent
US5728751A (en) * 1996-11-25 1998-03-17 Meadox Medicals, Inc. Bonding bio-active materials to substrate surfaces
US5877263A (en) * 1996-11-25 1999-03-02 Meadox Medicals, Inc. Process for preparing polymer coatings grafted with polyethylene oxide chains containing covalently bonded bio-active agents
US5733330A (en) * 1997-01-13 1998-03-31 Advanced Cardiovascular Systems, Inc. Balloon-expandable, crush-resistant locking stent
US5874101A (en) * 1997-04-14 1999-02-23 Usbiomaterials Corp. Bioactive-gel compositions and methods
US6042875A (en) * 1997-04-30 2000-03-28 Schneider (Usa) Inc. Drug-releasing coatings for medical devices
US20020004060A1 (en) * 1997-07-18 2002-01-10 Bernd Heublein Metallic implant which is degradable in vivo
US6174330B1 (en) * 1997-08-01 2001-01-16 Schneider (Usa) Inc Bioabsorbable marker having radiopaque constituents
US6010445A (en) * 1997-09-11 2000-01-04 Implant Sciences Corporation Radioactive medical device and process
US6015541A (en) * 1997-11-03 2000-01-18 Micro Therapeutics, Inc. Radioactive embolizing compositions
US6511748B1 (en) * 1998-01-06 2003-01-28 Aderans Research Institute, Inc. Bioabsorbable fibers and reinforced composites produced therefrom
US6709379B1 (en) * 1998-11-02 2004-03-23 Alcove Surfaces Gmbh Implant with cavities containing therapeutic agents
US6187045B1 (en) * 1999-02-10 2001-02-13 Thomas K. Fehring Enhanced biocompatible implants and alloys
US6183505B1 (en) * 1999-03-11 2001-02-06 Medtronic Ave, Inc. Method of stent retention to a delivery catheter balloon-braided retainers
US6177523B1 (en) * 1999-07-14 2001-01-23 Cardiotech International, Inc. Functionalized polyurethanes
US6706273B1 (en) * 1999-08-14 2004-03-16 Ivoclar Vivadent Ag Composition for implantation into the human and animal body
US6360577B2 (en) * 1999-09-22 2002-03-26 Scimed Life Systems, Inc. Apparatus for contracting, or crimping stents
US6689375B1 (en) * 1999-11-09 2004-02-10 Coripharm Medizinprodukte Gmbh & Co. Kg Resorbable bone implant material and method for producing the same
US20030028246A1 (en) * 1999-11-19 2003-02-06 Palmaz Julio C. Compliant implantable medical devices and methods of making same
US20020002399A1 (en) * 1999-12-22 2002-01-03 Huxel Shawn Thayer Removable stent for body lumens
US6537589B1 (en) * 2000-04-03 2003-03-25 Kyung Won Medical Co., Ltd. Calcium phosphate artificial bone as osteoconductive and biodegradable bone substitute material
US6527801B1 (en) * 2000-04-13 2003-03-04 Advanced Cardiovascular Systems, Inc. Biodegradable drug delivery material for stent
US6517888B1 (en) * 2000-11-28 2003-02-11 Scimed Life Systems, Inc. Method for manufacturing a medical device having a coated portion by laser ablation
US20030033001A1 (en) * 2001-02-27 2003-02-13 Keiji Igaki Stent holding member and stent feeding system
US20050004663A1 (en) * 2001-05-07 2005-01-06 Llanos Gerard H. Heparin barrier coating for controlled drug release
US6679980B1 (en) * 2001-06-13 2004-01-20 Advanced Cardiovascular Systems, Inc. Apparatus for electropolishing a stent
US6695920B1 (en) * 2001-06-27 2004-02-24 Advanced Cardiovascular Systems, Inc. Mandrel for supporting a stent and a method of using the mandrel to coat a stent
US20030028241A1 (en) * 2001-08-02 2003-02-06 Stinson Jonathan Swift Method for enhancing sheet or tubing metal stent radiopacity
US20040000361A1 (en) * 2002-06-27 2004-01-01 Thomas Trozera Method of manufacturing an implantable stent having improved mechanical properties
US6846323B2 (en) * 2003-05-15 2005-01-25 Advanced Cardiovascular Systems, Inc. Intravascular stent
US20090012598A1 (en) * 2004-06-29 2009-01-08 Abbate Anthony J Method of fabricating an implantable medical device by deformation of a tube or a sheet
US20080001333A1 (en) * 2006-06-30 2008-01-03 Klaus Kleine Method of fabricating a stent with features by blow molding
US20090005860A1 (en) * 2007-06-27 2009-01-01 Gale David C Method to fabricate a stent having selected morphology to reduce restenosis
US20090001633A1 (en) * 2007-06-29 2009-01-01 Limon Timothy A Method Of Manufacturing A Stent From A Polymer Tube

Cited By (110)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8999364B2 (en) 2004-06-15 2015-04-07 Nanyang Technological University Implantable article, method of forming same and method for reducing thrombogenicity
US20090012598A1 (en) * 2004-06-29 2009-01-08 Abbate Anthony J Method of fabricating an implantable medical device by deformation of a tube or a sheet
US8192678B2 (en) * 2004-07-26 2012-06-05 Advanced Cardiovascular Systems, Inc. Method of fabricating an implantable medical device with biaxially oriented polymers
US8715564B2 (en) 2004-07-26 2014-05-06 Advanced Cardiovascular Systems, Inc. Method of fabricating an implantable medical device with biaxially oriented polymers
US9517149B2 (en) 2004-07-26 2016-12-13 Abbott Cardiovascular Systems Inc. Biodegradable stent with enhanced fracture toughness
US20110079941A1 (en) * 2004-07-26 2011-04-07 Bin Huang Method of fabricating an implantable medical device with biaxially oriented polymers
US8778256B1 (en) 2004-09-30 2014-07-15 Advanced Cardiovascular Systems, Inc. Deformation of a polymer tube in the fabrication of a medical article
US8043553B1 (en) 2004-09-30 2011-10-25 Advanced Cardiovascular Systems, Inc. Controlled deformation of a polymer tube with a restraining surface in fabricating a medical article
US20060076708A1 (en) * 2004-09-30 2006-04-13 Bin Huang Method of fabricating a biaxially oriented implantable medical device
US8173062B1 (en) 2004-09-30 2012-05-08 Advanced Cardiovascular Systems, Inc. Controlled deformation of a polymer tube in fabricating a medical article
US7875233B2 (en) 2004-09-30 2011-01-25 Advanced Cardiovascular Systems, Inc. Method of fabricating a biaxially oriented implantable medical device
US20110144737A1 (en) * 2005-12-13 2011-06-16 Robert Burgermeister Polymeric stent having modified molecular structures
US7914573B2 (en) * 2005-12-13 2011-03-29 Cordis Corporation Polymeric stent having modified molecular structures
US20070134289A1 (en) * 2005-12-13 2007-06-14 Robert Burgermeister Polymeric stent having modified molecular structures
US7927529B2 (en) 2006-01-06 2011-04-19 Cordis Corporation Method of forming bioabsorbable drug delivery devices
US20090026650A1 (en) * 2006-01-06 2009-01-29 Vipul Bhupendra Dave Method of forming a bioabsorbable drug delivery devices
US20070160672A1 (en) * 2006-01-06 2007-07-12 Vipul Bhupendra Dave Methods of making bioabsorbable drug delivery devices comprised of solvent cast films
US20070162110A1 (en) * 2006-01-06 2007-07-12 Vipul Bhupendra Dave Bioabsorbable drug delivery devices
US20070158880A1 (en) * 2006-01-06 2007-07-12 Vipul Bhupendra Dave Methods of making bioabsorbable drug delivery devices comprised of solvent cast tubes
US9216238B2 (en) 2006-04-28 2015-12-22 Abbott Cardiovascular Systems Inc. Implantable medical device having reduced chance of late inflammatory response
US20080132995A1 (en) * 2006-05-12 2008-06-05 Robert Burgermeister Balloon expandable bioabsorbable drug eluting stent
AU2007249229B2 (en) * 2006-05-12 2013-05-23 Cardinal Health 529, Llc Balloon expandable bioabsorbable drug eluting flexible stent
US20080046068A1 (en) * 2006-05-12 2008-02-21 Robert Burgermeister Balloon expandable bioabsorbable drug eluting flexible stent
US9393135B2 (en) * 2006-05-12 2016-07-19 CARDINAL HEALTH SWITZERLAND 515 GmbH Balloon expandable bioabsorbable drug eluting stent
US9320837B2 (en) * 2006-05-12 2016-04-26 CARDINAL HEALTH SWITZERLAND 515 GmbH Balloon expandable bioabsorbable drug eluting flexible stent
US20080097620A1 (en) * 2006-05-26 2008-04-24 Nanyang Technological University Implantable article, method of forming same and method for reducing thrombogenicity
WO2007142736A3 (fr) * 2006-05-30 2008-01-31 Abbott Cardiovascular Systems Processus de fabrication pour stents polymériques
US9554925B2 (en) 2006-05-30 2017-01-31 Abbott Cardiovascular Systems Inc. Biodegradable polymeric stents
US20070283552A1 (en) * 2006-05-30 2007-12-13 Gale David C Manufacturing process for polymeric stents
US9198782B2 (en) 2006-05-30 2015-12-01 Abbott Cardiovascular Systems Inc. Manufacturing process for polymeric stents
WO2007142736A2 (fr) * 2006-05-30 2007-12-13 Abbott Cardiovascular Systems Inc. Processus de fabrication pour stents polymériques
US20110224778A1 (en) * 2006-05-30 2011-09-15 Advanced Cardiovascular Systems, Inc. Stent pattern for polymeric stents
US7971333B2 (en) 2006-05-30 2011-07-05 Advanced Cardiovascular Systems, Inc. Manufacturing process for polymetric stents
US10390979B2 (en) 2006-05-30 2019-08-27 Advanced Cardiovascular Systems, Inc. Manufacturing process for polymeric stents
US8658081B2 (en) * 2006-06-15 2014-02-25 Advanced Cardiovascular Systems, Inc. Methods of fabricating stents with enhanced fracture toughness
US20100289191A1 (en) * 2006-06-15 2010-11-18 Advanced Cardiovascular Systems, Inc. Methods of fabricating stents with enhanced fracture toughness
US8323329B2 (en) 2006-06-15 2012-12-04 Advanced Cardiovascular Systems, Inc. Stents with enhanced fracture toughness
US9522503B2 (en) 2006-06-15 2016-12-20 Abbott Cardiovascular Systems Inc. Methods of treatment with stents with enhanced fracture toughness
US7731890B2 (en) 2006-06-15 2010-06-08 Advanced Cardiovascular Systems, Inc. Methods of fabricating stents with enhanced fracture toughness
US20110112627A1 (en) * 2006-06-15 2011-05-12 Advanced Cardiovascular Systems, Inc. Stents with Enhanced Fracture Toughness
US20070293938A1 (en) * 2006-06-15 2007-12-20 Gale David C Methods of fabricating stents with enhanced fracture toughness
WO2007149457A1 (fr) * 2006-06-19 2007-12-27 Abbott Cardiovascular Systems Inc. Fabrication d'un stent avec des propriétés choisies dans les directions radiale et axiale
US20070290412A1 (en) * 2006-06-19 2007-12-20 John Capek Fabricating a stent with selected properties in the radial and axial directions
US7740791B2 (en) 2006-06-30 2010-06-22 Advanced Cardiovascular Systems, Inc. Method of fabricating a stent with features by blow molding
US20080001333A1 (en) * 2006-06-30 2008-01-03 Klaus Kleine Method of fabricating a stent with features by blow molding
US20100256742A1 (en) * 2006-06-30 2010-10-07 Klaus Kleine Tapered Polymeric Stent And Method Of Fabricating Same
US8099849B2 (en) * 2006-12-13 2012-01-24 Abbott Cardiovascular Systems Inc. Optimizing fracture toughness of polymeric stent
US20080147164A1 (en) * 2006-12-13 2008-06-19 Gale David C Optimizing fracture toughness of polymeric stent
US8303644B2 (en) 2007-05-04 2012-11-06 Abbott Cardiovascular Systems Inc. Stents with high radial strength and methods of manufacturing same
US8002817B2 (en) 2007-05-04 2011-08-23 Abbott Cardiovascular Systems Inc. Stents with high radial strength and methods of manufacturing same
JP2014158945A (ja) * 2007-05-04 2014-09-04 Abbott Cardiovascular Systems Inc 半径方向の高い強度を備えたステントおよびその製造方法
US9079354B2 (en) 2007-05-04 2015-07-14 Abbott Cardiovascular Systems Inc. Radially expandable polymer prosthesis and method of making same
US20130181380A1 (en) * 2007-05-04 2013-07-18 Abbott Cardiovascular Systems Inc. Method of Making a Polymeric Stent
EP2604230A1 (fr) * 2007-05-04 2013-06-19 Abbott Cardiovascular Systems Inc. Endoprothèses vasculaires à haute résistance radiale et procédés de fabrication associés
WO2008137821A1 (fr) * 2007-05-04 2008-11-13 Abbott Cardiovascular System Inc. Endoprothèses vasculaires à haute résistance radiale, et leur procédé de fabrication
US20100274349A1 (en) * 2007-05-04 2010-10-28 Brenna Hearn Lord Stents with High Radial Strength and Methods of Manufacturing Same
US7666342B2 (en) 2007-06-29 2010-02-23 Abbott Cardiovascular Systems Inc. Method of manufacturing a stent from a polymer tube
US20090001633A1 (en) * 2007-06-29 2009-01-01 Limon Timothy A Method Of Manufacturing A Stent From A Polymer Tube
US20090146348A1 (en) * 2007-12-11 2009-06-11 Bin Huang Method of fabrication a stent from blow molded tubing
EP2647484A1 (fr) * 2007-12-11 2013-10-09 Abbott Cardiovascular Systems Inc. Procédé de fabrication d'une endoprothèse à partir d'un tubage moulé par soufflage
US8658082B2 (en) 2007-12-11 2014-02-25 Abbott Cardiovascular Systems Inc. Method of fabricating stents from blow molded tubing
US8268228B2 (en) 2007-12-11 2012-09-18 Abbott Cardiovascular Systems Inc. Method of fabricating stents from blow molded tubing
JP2011505982A (ja) * 2007-12-11 2011-03-03 アボット カルディオバスキュラー システムズ インコーポレーテッド ブローモールド成形チューブからステントを製作する方法
WO2009076350A1 (fr) 2007-12-11 2009-06-18 Abbott Cardiovascular Systems Inc. Procédé de fabrication d'endoprothèse vasculaire à partir d'un tubage moulé par soufflage
EP2397306A3 (fr) * 2007-12-11 2013-03-27 Abbott Cardiovascular Systems Inc. Procédé de fabrication d'une endoprothèse à partir d'un tubage moulé par soufflage
US20090163989A1 (en) * 2007-12-19 2009-06-25 Contiliano Joseph H Balloon expandable bioabsorbable stent with a single stress concentration region interconnecting adjacent struts
US7972373B2 (en) 2007-12-19 2011-07-05 Advanced Technologies And Regenerative Medicine, Llc Balloon expandable bioabsorbable stent with a single stress concentration region interconnecting adjacent struts
US7981149B2 (en) 2007-12-19 2011-07-19 Advanced Technologies And Regenerative Medicine, Llc Balloon expandable bioabsorbable stent with a single stress concentration region interconnecting adjacent struts
US20100249905A1 (en) * 2007-12-19 2010-09-30 Contiliano Joseph H Balloon expandable bioabsorbable stent with a single stress concentration region interconnecting adjacent struts
US20090248147A1 (en) * 2008-03-31 2009-10-01 Yunbing Wang Stent With Nucleating Agent
US8252215B2 (en) 2008-03-31 2012-08-28 Abbott Cardiovascular Systems Inc. Method for fabricating a stent with nucleating agent
US8852263B2 (en) 2008-03-31 2014-10-07 Abbott Cardiovascular Systems Inc. Stent with nucleating agent
US8388673B2 (en) 2008-05-02 2013-03-05 Abbott Cardiovascular Systems Inc. Polymeric stent
US9908143B2 (en) 2008-06-20 2018-03-06 Amaranth Medical Pte. Stent fabrication via tubular casting processes
US10646359B2 (en) 2008-06-20 2020-05-12 Amaranth Medical Pte. Stent fabrication via tubular casting processes
US10893960B2 (en) 2008-06-20 2021-01-19 Razmodics Llc Stent fabrication via tubular casting processes
US11931484B2 (en) 2008-06-20 2024-03-19 Razmodics Llc Composite stent having multi-axial flexibility and method of manufacture thereof
US7770467B1 (en) 2008-08-04 2010-08-10 Abbott Cardiovascular Systems Inc. Fixture for mechanical analysis of a hollow tube
US8303296B2 (en) 2008-08-04 2012-11-06 Abbott Cardiovascular Systems Inc. Polymer tube expansion apparatus to maximize fracture toughness
US8828305B2 (en) 2008-08-04 2014-09-09 Abbott Cardiovascular Systems Inc. Tube expansion processes for semicrystalline polymers to maximize fracture toughness
US8006568B2 (en) 2008-08-04 2011-08-30 Abbott Cardiovascular Systems Inc. Fixture for mechanical analysis of a hollow tube
US8012402B2 (en) 2008-08-04 2011-09-06 Abbott Cardiovascular Systems Inc. Tube expansion process for semicrystalline polymers to maximize fracture toughness
US20100025894A1 (en) * 2008-08-04 2010-02-04 Abbott Cardiovascular Inc. Tube expansion process for semicrystalline polymers to maximize fracture toughness
US20100251838A1 (en) * 2008-08-04 2010-10-07 Abbott Cardiovascular Systems Inc. Fixture for Mechanical Analysis of a Hollow Tube
US20100244304A1 (en) * 2009-03-31 2010-09-30 Yunbing Wang Stents fabricated from a sheet with increased strength, modulus and fracture toughness
US8545742B2 (en) * 2009-08-28 2013-10-01 Abbott Cardiovascular Systems Inc. Method of fabricating a low crystallinity poly(L-lactide) tube
WO2011031423A3 (fr) * 2009-08-28 2012-02-16 Abbott Cardiovascular Systems Inc. Procédé de fabrication d'un tube de poly(l-lactide) de faible cristallinité
US20110049751A1 (en) * 2009-08-28 2011-03-03 Abbott Cardiovascular Systems Inc. Method Of Fabricating A Low Crystallinity Poly(L-Lactide) Tube
US20110066222A1 (en) * 2009-09-11 2011-03-17 Yunbing Wang Polymeric Stent and Method of Making Same
US9211682B2 (en) 2009-09-14 2015-12-15 Abbott Cardiovascular Systems Inc. Controlling crystalline morphology of a bioabsorbable stent
US8501079B2 (en) 2009-09-14 2013-08-06 Abbott Cardiovascular Systems Inc. Controlling crystalline morphology of a bioabsorbable stent
US20110062638A1 (en) * 2009-09-14 2011-03-17 Thierry Glauser Controlling Crystalline Morphology Of A Bioabsorbable Stent
US10123894B2 (en) 2010-01-30 2018-11-13 Abbott Cardiovascular Systems Inc. Method of crimping stent on catheter delivery assembly
US9198785B2 (en) 2010-01-30 2015-12-01 Abbott Cardiovascular Systems Inc. Crush recoverable polymer scaffolds
US9763818B2 (en) 2010-01-30 2017-09-19 Abbott Cardiovascular Systems Inc. Method of crimping stent on catheter delivery assembly
US9770351B2 (en) 2010-01-30 2017-09-26 Abbott Cardiovascular Systems Inc. Crush recoverable polymer scaffolds
US9827119B2 (en) 2010-01-30 2017-11-28 Abbott Cardiovascular Systems Inc. Polymer scaffolds having a low crossing profile
US9867728B2 (en) 2010-01-30 2018-01-16 Abbott Cardiovascular Systems Inc. Method of making a stent
US11324614B2 (en) 2010-01-30 2022-05-10 Abbott Cardiovascular Systems Inc. Balloon expanded polymer stent
US8370120B2 (en) 2010-04-30 2013-02-05 Abbott Cardiovascular Systems Inc. Polymeric stents and method of manufacturing same
US20120280432A1 (en) * 2011-05-06 2012-11-08 Industrial Technology Research Institute Method for manufacturing bioabsorbable stents
US8747728B2 (en) 2011-05-24 2014-06-10 Abbott Cardiovascular Systems Inc. Method and system for manufacturing a polymer endoprosthesis by injection molding and blow molding
US10307274B2 (en) 2011-07-29 2019-06-04 Abbott Cardiovascular Systems Inc. Methods for uniform crimping and deployment of a polymer scaffold
US10299944B2 (en) 2012-09-24 2019-05-28 Arterius Limited Method of producing a tube for use in the formation of a stent, and such tube
GB2512016A (en) * 2012-09-24 2014-09-24 Arterius Ltd Methods
US9517150B2 (en) * 2012-10-23 2016-12-13 Abbott Cardiovascular Systems Inc. Time-dependent polymer scaffolds
US20140114398A1 (en) * 2012-10-23 2014-04-24 Abbott Cardiovascular Systems Inc. Time-dependent polymer scaffolds
US11135074B2 (en) 2012-10-23 2021-10-05 Abbott Cardiovascular Systems Inc. Methods for vascular restoration therapy
US9364588B2 (en) 2014-02-04 2016-06-14 Abbott Cardiovascular Systems Inc. Drug delivery scaffold or stent with a novolimus and lactide based coating such that novolimus has a minimum amount of bonding to the coating
CN114101472A (zh) * 2021-11-30 2022-03-01 内蒙古工业大学 一种铝合金蠕变时效成型设备

Also Published As

Publication number Publication date
WO2006014747A1 (fr) 2006-02-09
US8715564B2 (en) 2014-05-06
JP4782121B2 (ja) 2011-09-28
US20140228929A1 (en) 2014-08-14
US20120217672A1 (en) 2012-08-30
EP1773566A1 (fr) 2007-04-18
JP2008507439A (ja) 2008-03-13
US20110079941A1 (en) 2011-04-07
EP1773566B1 (fr) 2016-08-31
US8192678B2 (en) 2012-06-05

Similar Documents

Publication Publication Date Title
US8192678B2 (en) Method of fabricating an implantable medical device with biaxially oriented polymers
US7875233B2 (en) Method of fabricating a biaxially oriented implantable medical device
US9023262B2 (en) Method of fabricating an implantable medical device using gel extrusion and charge induced orientation
US8043553B1 (en) Controlled deformation of a polymer tube with a restraining surface in fabricating a medical article
EP2046411B1 (fr) Fabrication d'un stent avec des propriétés choisies dans les directions radiale et axiale
US9808982B2 (en) Tapered polymeric stent and method of fabricating same
EP2429601B1 (fr) Fabrication d'un dispositif médical implantable à partir d'une construction polymérique amorphe ou de très faible cristallinité
US10058439B2 (en) Deformation of a polymer tube in the fabrication of a medical article
US20070293938A1 (en) Methods of fabricating stents with enhanced fracture toughness
US8173062B1 (en) Controlled deformation of a polymer tube in fabricating a medical article
EP2647484A1 (fr) Procédé de fabrication d'une endoprothèse à partir d'un tubage moulé par soufflage
US8241554B1 (en) Method of forming a stent pattern on a tube
US20070179219A1 (en) Method of fabricating an implantable medical device using gel extrusion and charge induced orientation

Legal Events

Date Code Title Description
AS Assignment

Owner name: ADVANCED CARDIOVASCULAR SYSTEMS, INC., CALIFORNIA

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:HUANG, BIN;SCHAIBLE, STEPHEN;KAUFMAN, RICHARD;AND OTHERS;REEL/FRAME:015923/0563;SIGNING DATES FROM 20040719 TO 20040726

STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION

点击 这是indexloc提供的php浏览器服务，不要输入任何密码和下载